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Abstract 
Myocardial ischaemia causes progressive cellular injury. Initially there is loss of function, followed 
by formation of oedema. Ischemia, if prolonged, will eventually lead to cell death. 
Revascularisation of occluded coronary arteries is an efficient tool to reduce infarct size in acute 
myocardial infarction. However, reperfusion in itself can be associated with a significant amount 
of myocardial damage. The structural and metabolic changes occurring in myocardial ischemia 
and reperfusion can now be studied in-vivo using magnetic resonance imaging (MRI) and are 
targets to optimise the treatment of patients with acute myocardial ischemia. 
The development of new MRI techniques for T1 mapping allows the study of the evolution of 
myocardial oedema in both humans and animals. Moreover, hyperpolarised MR spectroscopy 
(MRS) allows the non-invasive assessment of myocardial metabolism, as injected hyperpolarised 
molecules can be used to study the function of metabolic pathways and enzymes in the setting of 
ischaemia and reperfusion.  
The aims of this project were to develop an animal model to allow the study of myocardial 
ischemia in real time, and then use this model to study the acute development of oedema and 
the metabolic changes in the metabolism of pyruvate. 
With the use of a vascular occluder, we successfully developed a closed-chest model of 
ischemia in the rat. This model allowed the animals to recover from the stress of surgery while 
also allowing ischemia experiments to be carried while the animals remain in the bore of the 
scanner. We then proceeded to validate this model and validate a new MR sequence, which 
produces cine-MR, T1 mapping and inversion-recovery prepared images. We studied the effects 
of varying durations of myocardial ischemia on the development of myocardial infarction and 
used this to validate the Small Animal Look-Locker Inversion Recovery (SALLI) multimodal 
imaging sequence. We were also able to study the development of myocardial oedema in real 
time, and demonstrate that preconditioning attenuated the T1 lengthening effects of myocardial 
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ischemia. Following this, the acute changes in pyruvate metabolism occurring in the myocardial 
area at risk following 15 minutes of myocardial ischemia were investigated. We were able to 
detect abnormal metabolism in the area at risk for the first 60 minutes following ischemia and 
demonstrated that metabolism returned to normal 1 week after ischemia. The methods used 
show much promise in the study of the changes occurring in myocardial ischemia-reperfusion, 
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Chapter 1 –  Thesis Introduction 
1.1 Introduction 
Despite the striking advances in medical treatment, cardiovascular diseases remain a leading 
cause of morbidity and mortality. Further understanding of the processes of myocardial ischemia 
is essential to improve the treatment and prognosis of patients undergoing myocardial infarction. 
Patients who present with chest pain represent a group with a broad range of possible 
diagnoses. Cardiac magnetic resonance imaging (CMR) already plays an significant role in many 
centres, diagnosing acute myocardial infarction and giving important prognostic information 
about myocardial viability.   
Further improvements are required in the area of the study of the myocardial area at risk (AAR); 
that is the myocardial tissue within the perfusion bed distal to the culprit lesion of the infarct-
related coronary artery. For example, while CMR can detect acute myocardial injury in ischemia 
and myocarditis there is controversy about the role of CMR in the assessment of the size of the 
AAR (1, 2). As CMR does not involve radiation, it is an ideal method to study the pathological 
changes occurring following myocardial ischemia. Recent studies have demonstrated how 
dynamic the changes can be in response to myocardial injury, for example, myocardial water 
content appears to have a bimodal pattern following myocardial ischaemia/reperfusion (3). The 
recent development of methods to characterise the myocardium in-vivo now presents the 
possibility of whole-heart “non-invasive myocardial biopsy” (4).  
CMR may be able to provide more information than the static information provided by biopsies, 
as developments in spectroscopy now offer the possibility of studying myocardial metabolism at 
baseline and in response to stresses such as myocardial ischemia. Until now, oedema imaging 
using CMR has played an important role in the diagnosis of acute injury and the detection of the 
AAR. Nuclear imaging techniques used changes in metabolism to identify the AAR (5). We aim 
to use hyperpolarised spectroscopic techniques to study in-vivo the rapid metabolic changes in 
the AAR. These changes have the potential to delineate the AAR, and to further our 
understanding of the processes of myocardial injury, cell death and myocardial reperfusion and 
reperfusion injury. For example, as of yet there is no method available to assess the magnitude 
of reperfusion injury in-vivo in patients. 
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Myocardial ischaemia occurs when the blood supply is unable to match the metabolic needs of 
the myocardium. As oxygen supply is limited, the cell shifts from aerobic metabolism to 
anaerobic metabolism to provide the cell with energy to maintain the functions of contraction, 
relaxation and homeostasis. When ischaemia is prolonged, contractile function ceases. Cellular 
homeostasis becomes deranged, with the failure of the cell membrane pumps that maintain 
intracellular fluid balance, before finally, the development of cellular rupture. This switch from 
aerobic to anaerobic metabolism could be used as a tool to detect the effects of myocardial 
ischaemia, and to study in-vivo the pathological processes involved in cell death in myocardial 
ischaemia. 
The goal of treatments for myocardial ischaemia caused by coronary occlusion is the rapid 
reperfusion of the myocardium by reopening the coronary artery, either by using lytic drugs to 
dissolve the occluding thrombus or by percutaneous coronary intervention. Although this 
treatment results in salvage of the myocardium in the AAR, reperfusion itself may be associated 
with further injury (6). Currently, myocardial revascularization occurs rapidly after patients 
present to medical services, and further decreases in median time to revascularization (from 83 
to 67 minutes) do not appear to be associated with reduced mortality (7). Alternative strategies to 
minimise myocardial injury are required, with reperfusion injury a prominent target. Strategies to 
increase myocardial salvage, the amount of myocardium in the AAR that remains viable, include 
pre- and postconditioning. The process of preconditioning was first described in a seminal paper 
nearly 30 years ago (8), which described how brief episodes of ischemia preceding prolonged 
coronary occlusion led to a reduction in the final size of myocardial infarction. This study was 
followed by others suggesting that both brief episodes of ischemia following reperfusion – 
postconditioning, and brief episodes of ischemia in a distal organ – remote conditioning, could 
lead to a reduction in infarction size. The mechanisms of this process are not completely 
understood but are thought to lead ultimately to a delay in the opening of the mitochondrial 
permeability transition pore (MPTP). This pore plays a crucial role in necrosis and apoptosis. The 
opening of this pore results in mitochondrial swelling and the uncoupling of oxidative 
phosphorylation (9). The mitochondria begin to break down ATP, starving the cell of energy, with 
disruption of cellular homeostasis. Therapies focused on preventing or delaying MPTP opening 
have received much attention but have yet to demonstrate a clinical benefit (10). 
21 
 
CMR has developed into the gold standard method of measurement of myocardial systolic 
function and in-vivo measurement of myocardial infarction using late gadolinium enhancement 
(LGE) (11). LGE can characterise myocardium in vivo, and is superior in the detection of both 
subendocardial infarction and defining the extent of transmural myocardial infarction to previously 
available nuclear imaging methods (12, 13). This technique has allowed clinicians to divide 
myocardium into viable and infarcted myocardium. However, in reality, the border zones of 
myocardial infarction may contain a mixture of both viable and infarcted myocardium, a so-called 
“grey zone” (14). LGE imaging is excellent in detecting infarction (white) and normal (black) 
myocardium, but assessment of this “grey zone” is challenging, as LGE does not provide a 
quantitative measurement of the degree of enhancement.  
In patients with ischemic cardiomyopathy, myocardium remote from the infarction remodels, 
becoming hypokinetic and dilated, and develops increasing levels of myocardial fibrosis (15). 
Increased myocardial fibrosis is also seen in patients with dilated cardiomyopathy (16). In both of 
these conditions, LGE is unable to quantify this increased fibrosis as this technique requires the 
presence of a contrast difference between normal and pathological myocardium. These demands 
led to the development of advanced techniques to characterise the myocardium, including T1 and 
T2 mapping. 
CMR uses differences in the relaxation properties of protons, predominantly found in water and 
fat in the body to generate image contrast. These relaxation properties, T1 and T2, can be 
quantified, but until recently, the motion of the heart presented difficulties in these 
measurements. Cardiac pulse sequences developments now allow the generation of myocardial 
maps, where each voxel has a value for the relaxation property of interest. As the relaxation 
properties are based largely on the water content and binding of water in a tissue, each tissue 
will have a normal range of T1 and T2 values. Changes in native myocardial T1 and T2 have been 
used to detect the AAR (17), probe acute and chronic myocardial infarction (18, 19) and 
myocarditis (15). This native T1 value reflects composite water signal from interstitium and 
myocytes, and therefore reflects myocardial water content. Gadolinium contrast agents are also 
used to characterise the myocardium. As gadolinium remains extracellular, changes in T1 
following injection of contrast reflect changes in the extracellular space. This value, known as 
post-contrast T1, can be compared with the native T1 value. The development of these imaging 
22 
 
techniques now allows insight into the formation of myocardial oedema and changes in the 
intracellular and extracellular space, all significant processes in the pathology of myocardial 
ischemia and infarction. 
It is now clear that CMR can assess myocardial function and characterise the myocardium. It has 
also been possible for many years to use MRI to study myocardial metabolism. However, the 
spectroscopic techniques used were limited by a low signal to noise ratio, low temporal and 
spatial resolution and low reproducibility. Recent developments, known as hyperpolarised 
spectroscopy, have the potential to increase signal to noise ratios by 10,000-100,000, allowing 
unprecedented study of the myocardial metabolism (20). This technique uses a carbon-
containing molecule of low molecular weight, such as pyruvate, to probe metabolic pathways. 
Simply, the substrate of interest is frozen and hyperpolarised, a process where the near 
complete polarisation of electrons at low temperatures and high magnetic field strengths is 
transferred to the molecule of interest. This molecule is then rapidly dissolved and injected into 
the subject of interest. As pyruvate sits at a central point between glycolysis and the Krebs cycle, 
hyperpolarised spectroscopy can provide information about the metabolism of carbohydrates in 
the cell. A particular challenge of this technique is the rapid decay of the hyperpolarised signal. 
However, this can be seen as an advantage, as it allows sequential studies to be carried out 
without interference from preceding injections. 
  
1.1 Aim 
The aim of this thesis was to study the structural and metabolic changes occurring in acute 
myocardial ischemia using both T1 mapping techniques and hyperpolarised 13C spectroscopic 
imaging. Firstly, a suitable animal model needed to be established, followed by the development 
and adaptation of methods of T1 mapping and hyperpolarised imaging to allow the study of the 




1.2 Outline of thesis 
Chapter 2 outlines some of the basics of nuclear magnetic resonance and MRI, including an 
overview of some of the imaging techniques and the technique of 13C dynamic nuclear 
polarisation (DNP). 
Chapter 3 then describes the history and development of T1 mapping, followed by its cardiac 
application, including in acute and chronic myocardial infarction, and the native and post-contrast 
uses (published as Review paper: O h-Ici et al., T1 mapping in ischaemic heart disease. Eur 
Heart J Cardiovasc Imaging. 2014 Jun;15(6):597-602). 
To study the changes in acute myocardial ischemia, we first needed to develop a suitable model. 
Although the open chest myocardial infarction model in the rat is well developed, this model was 
not suitable for our purposes. Any repositioning of the animal to occlude the coronary artery 
would interfere with the study of the acute phases of ischemia. A model was required that could 
allow myocardial ischemia to be caused while the animal was in the bore of the scanner. Chapter 
4 describes the development of this model (published as Original paper: O h-Ici et al. Closed-
chest small animal model to study myocardial infarction in an MRI environment in real time. Int J 
Cardiovasc Imaging. 2015 Jan;31(1):115-21). 
Although a technique for small animal cardiac T1 mapping had already been developed (21) (22), 
there remained other aspects of this imaging technique to be validated. In particular, the Small 
Animal Look-Locker technique is one which produces not only T1 maps but also generates cine-
MR and inversion recovery images. Chapter 5 describes the validation of these aspects of this 
technique against conventional small animal cine-MR techniques and staining for myocardial 
infarction (submitted as Original paper: O h-Ici et al. Validation of SALLI, a multimodal T1 
mapping method, for the evaluation of ventricular systolic function and late gadolinium 
enhancement). 
Having developed the small animal model, Chapter 6 describes our studies of the acute changes 
in myocardial T1 values following different periods of myocardial ischemia and reperfusion. We 
were able to examine the development of myocardial oedema following coronary occlusion, and 
then assess the effects of preconditioning on the development of myocardial oedema (submitted 
as Original paper: O h-Ici et al. T1 mapping in acute myocardial ischemia/reperfusion). 
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We then used the closed-chest model to study the effects of myocardial ischemia on the 
carbohydrate metabolism in Chapter 7. We were able to detect changes in the aerobic and 
anaerobic metabolism of pyruvate following myocardial reperfusion, and study the duration of 
these changes in the first hour after reperfusion, and one week later (O h-Ici et al. Hyperpolarized 
Metabolic MR Imaging of Acute Myocardial Changes and Recovery Upon Ischemia-Reperfusion 
in a Small Animal Model. Radiology 2016 Mar;278(3):742-51). 
Finally, in Chapter 8, the main achievements of this thesis are summarised, and future areas of 
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Chapter 2 - Overview and History of MR spectroscopy and 
imaging 
 
"You know, what these people do is really very clever. They put little spies into the molecules 
and send radio signals to them, and they have to radio back what they are seeing." 
 
Felix Bloch recalling Niels Bohr's description of Nuclear Magnetic Resonance. 
 
 
2.1 History of Magnetic Resonance 
Magnetic resonance imaging (MRI) can trace its development ultimately to spectroscopy, the 
study of the interaction of electromagnetic radiation with matter. Two particular developments in 
spectroscopy were of importance in the development of nuclear magnetic resonance (NMR). The 
first introduced magnetic fields into spectroscopy. It was observed by Zeeman in 1896 when he 
noted that a magnetic field could split the spectrum of the light emitted along the magnetic field 
(1). The second was the suggestion by Pauli in 1924 that atomic nuclei possess an intrinsic 
angular momentum (spin) and, parallel to this, a magnetic moment (2).  
Following on this knowledge, in the 1940s Felix Bloch and Edward Purcell developed a series of 
experiments to measure this magnetic moment (3, 4). Bloch initially gave his method the name of 
"nuclear induction," as it allowed the signal generated by the transition of nuclei from one energy 
level to another to be detected as a voltage difference. This method subsequently became 
known as nuclear magnetic resonance.  
It was first thought that a nucleus would have a specific resonance frequency, irrespective of its 
local chemical environment. However, in 1949 and 1950, it was found that the electron cloud 
surrounding the nucleus played a role in determining the resonance frequency (5). This 
difference became known as the chemical shift (6). It was also found that nuclei could interact 
with each other, or undergo spin-spin coupling, resulting in the splitting of the NMR spectra 
obtained (7). These discoveries moved NMR from the realm of physics into the world of 
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chemistry, allowing molecular structure to be studied (5, 8, 9). NMR was then adapted for the 
study of biological materials (10), followed by cells (11) and intact tissues (12). Some of these 
experiments may have been foreseen by Bloch when he placed his finger into the coil of his 
NMR probe and obtained a signal (13).  
While protons are abundant in biological compounds, early biological NMR studies focused on 
phosphorus-31 (31P) and carbon-13 (13C) (14). The large water signal in proton NMR interfered 
with the study of the much smaller signals from the other proton containing metabolites. Methods 
were developed to suppress the signal from water, allowing the development of proton NMR. It 
was found that the relaxation times of red blood cells varied with the surrounding water content 
(15), and subsequently that the relaxation times of tissues could change over the reproductive 
hormonal cycle (16). It was therefore suggested that the water content in cells affected relaxation 
times. A search for a method to distinguish healthy from cancerous tissue led to the claim that 
NMR properties of healthy tissue were significantly different from those of cancerous tissue (17). 
In the mid-1970s, Lauterbur (18), and Mansfield (19) discovered magnetic field gradients could 
be used for spatial localisation of the NMR signals. This discovery allowed the development of 
magnetic resonance imaging (MRI). These findings were aided by the development of two-
dimensional (2D) Fourier transformed NMR (20), resulting in more efficient imaging.  
In its short history, NMR and MRI have evolved into essential tools in the study of chemistry, 
biology and medicine: from the analysis of single compounds to the current possibilities of in-vivo 
analysis of changes in the metabolism and water content of living tissues. 
 
 
2.2 Basic Principles of MR 
2.2.1 Nuclear Spin 
Atoms consist of a positively charged nucleus surrounded by a negatively charged cloud of 
electrons. Certain nuclei, those with an odd number of protons and/or neutrons, spin on their 
nuclear axis. This nuclear spin I (21) of a positively charged object will generate a magnetic 
dipole, resembling a bar magnet. The magnetic dipole moment, µ and the angular momentum of 




 µ = γ𝐼       (2.1) 
Nuclear spin ranges from 0 to 8 across the periodic table. The spin of nuclei can be predicted 
from their mass number. Nuclei with an odd number of protons and/or neutrons possess in their 
ground state a nuclear spin > 0 (22). For example, 1H and 13C have a spin number of ½, whereas 
12C has a spin of 0.  
Spin is a type of angular momentum, which can be quantized into magnitude L, and a direction, 
m. The magnitude L is given by ħÖI(I+1), where ħ = h/2π and h is Plank’s constant. The magnetic 
quantum number m equals – I, - I + 1, . . . , I - 1, + I, resulting in a total number of eigenstates 
(spin states) of 2I+1. These eigenstates refer to the orientation of I along the direction of an 
external magnetic field B0.  
2.2.2 Nuclei in a Magnetic Field 
A nucleus with a magnetic moment in a magnetic field is classically compared to a spinning top, 
with a rotation about both its own axis and that of the external magnetic field. When a nucleus is 
placed in an external magnetic field, B-, its angular momentum prevents it from aligning itself 
parallel to B0. The spins will experience a torque, causing the nucleus to rotate or precess about 
B0 (Figure 2-1). This can be described as: 
   ./.0 = 𝛾𝜇×𝐵-			                   (2.2) 
The precessional frequency can be derived as: 
   𝜔- = 𝛾𝐵-                   (2.3) 
where ω- is the Larmor frequency, or the frequency of the precession of the nucleus and is 





Figure 2-1. The precession of a ½ spin magnetic moment µ	around a magnetic field B0 (A). Each NMR 
sample will contain a large number of precessing nuclei (B). The sum of all of these spins will result in a net 
magnetisation vector M0 (C). 
 
In the absence of a magnetic field, the nuclear spins will be randomly aligned, and have no net 
magnetic vector. When placed into a magnetic field, the spins will tend to align parallel or anti-
parallel with B-. These spin states are known as nuclear Zeeman levels (Figure 2-2). For I = 1/2 
spins, there are two equidistant energy levels in a magnetic field B0: 
   𝐸 = ±𝜇𝐵- = ± 89 𝛾ℏ𝐵-     (2.4) 
The spin states can be referred to as “up” or “down”, the low energy (a) and high energy (β) 
states respectively. From equation 2.4 it can be seen that the energy difference between the spin 
states is 















Figure 2-2. Nuclear Zeeman levels for a nucleus with spin ½. DE = għB0 
 
Therefore, if B- or g increase, DE will increase. The low sensitivity of proton NMR results from the 
small energy difference between the two energy states of the proton. In comparison, the g of an 
electron is approximately 660 times larger. This property is exploited in the field of dynamic 
nuclear polarisation addressed later in this chapter (22, 23). g is different for each nucleus. Nuclei 
with larger g can absorb/emit more energy and are therefore more sensitive for the purposes of 
NMR. This sensitivity is proportional to g3. The gyromagnetic ratios of nuclei of most interest in 






(rad T–1 s–1) 
Resonance 







with 1H (%) 
1H ½ 26.752  42.577 99.985 100.0 
2H 1 4.1066 6.536 0.015 0.96 
12C 0 – – 98.89 – 
13C ½ 6.7283 10.708  1.11 1.59 
16O 0 – – 99.76 – 
19F ½ 25.181 40.077 100.0 83.34 
31P ½ 10.841 17.254 100.0 6.63 
Table 2-1. NMR properties of selected nuclei used in biological NMR and MRI (24) 
 
It can be seen from Table 2-1 that spectroscopy of 13C is limited in comparison to hydrogen by its 
low natural abundance and its lower gyromagnetic ratio. The 12C isotope of carbon and the 16O 









The energy difference between the two population states is what enables NMR. If energy is 
supplied in the form of electromagnetic radiation of the correct frequency, this can cause the 
nuclei to flip from the lower energy state to the higher state. This phenomenon is known as 
nuclear magnetic resonance. 
 
2.2.3 Polarisation 
To generate a signal from NMR, the population of spins in the lower energy state must be greater 
than that of the higher energy state. The lower energy spins can then be excited, leading to an 
NMR signal. The difference in the spin states (spin excess), parallel (a) or anti-parallel (β) to the 
external magnetic field is known as polarisation. The larger the polarisation, the larger the 
potential NMR signal. Polarisation varies with thermal equilibrium and is given by the Boltzmann 
distribution:  
   <=<> = exp(∆CDE)      (2.6) 
where nα	and nβ	denote the population in each energy state, ∆E is the energy difference, k is the 
Boltzmann constant, and T is absolute temperature. From the equation, it can be seen that 
polarisation increases as absolute temperature decreases, or as field strength increases. 
 
 
Figure 2-3. The two energy states of a proton, lower energy +½ spin (a), and higher energy -½  (β) spin. 
 
At thermal equilibrium, this spin excess is very small and can be calculated. As γℏB- ≪ kT at 
room temperature and typical magnetic field strengths, equation 2.6 can be rewritten as  
𝑛𝛼𝑛𝛽 = 1 + 𝛾ℏ𝐵-𝑘𝑇  
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With this rewritten equation, polarisation can then be calculated. At room temperature and 1.0T, 
the number of excess protons in the low energy state is 3 per million, 3 x 10-6. Although the 
relative difference between spin states is very small, the absolute difference of spins in a sample 
will be very large. In-vivo MRI is possible as humans are made up predominantly of water (the 
heart is made of 73% water (25)). Each water molecule has 2 protons, with large numbers of 
protons (1021) in a typical MRI voxel. This results in 3 x 10-6 x 1021 or approximately 315 protons in 
the low energy state, a sufficient amount to generate a signal. 13C spectroscopy is limited by the 
low 𝛾 (Table 2-1) and much lower natural concentrations of the 13C nucleus (1.1%). At room 
temperature and a magnetic field strength of 3 T, the 13C spin polarisation is 2.47 ppm (26).  
 
2.2.4 Net Magnetisation 
For a sample containing many spins, there will be more spins aligned with B0, (parallel – low 
energy, a) than in the higher energy state (antiparallel – high energy, β) (Figure 2-3). The sum of 
all the spins will form a single net macroscopic magnetisation along the longitudinal plane (Figure 
2-1) (26). This 'longitudinal equilibrium magnetisation'  M0 for the vector of the magnetic moment 
along the external field direction can be calculated. For n spins, M0 is determined by the 
magnetic moment component of each spin multiplied by the net population difference:  
   M- = STUℏUVWX B-      (2-7) 
For in vivo studies, neither body temperature nor spin density can be changed, meaning that 
under normal conditions, M0 can only be increased by increasing B0. 
2.2.5 Magnetisation 
An NMR sample will contain a large number of spins. These spins will form two cones, parallel 
and anti-parallel (Figure 2-1). For simplicity, we align the z-axis with the external magnetic field. 
As there are more spins in the low-energy parallel state, we can reduce this to one cone 
precessing parallel to B0. As each spin will be randomly assigned along the surface of the cone, 
the transverse vector of the spins will cancel itself out. This results in a single vector M, along the 
z-axis. The magnetisation vector M can be described as the sum of motion for the individual 
spins:     
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.Y.0 = 𝛾𝑀×𝐵      (2.8)  
This expression forms the basis of the Bloch Equations (3, 27) and illustrates the interaction of 
spins with external magnetic fields. 
2.2.6 Excitation  
Before the magnetisation can be detected and measured, it must first be tilted into the transverse 
(xy) plane to allow for induction using a current loop placed perpendicular to the main magnetic 
field axis. This tilting is achieved by applying an RF pulse at the Larmor frequency of the nucleus 
of interest. This pulse creates a secondary magnetic field B1 in the xy plane. This B1 is a 
circularly polarised radio frequency (RF) field (Figure 2-4) that can be described as:  
   𝐵 𝑡 = 𝐵8𝑐𝑜𝑠𝜔𝑡𝑥 + 𝐵8𝑠𝑖𝑛𝜔𝑡𝑦    (2.9) 
M0 will spiral away from the z-axis towards the xy-axis, precessing around the B0 axis with a 
frequency ω- and around the B0 axis with ω8 = γB8 (Figure 2-4). The Bloch equation describes 
the behaviour of the macroscopic magnetisation vector as a result of the magnetic interactions 
with B1 and B0  (3, 27, 28):  
    .Y.0 = 	𝛾𝑀×(𝐵- + 𝐵8)     (2.10) 
 
Figure 2-4. The circularly polarised field of B1 is applied perpendicularly to B0. Seen from a rotating frame of 
reference (Figure 2-5), the magnetisation vector experiences B1 as a static field when B1 oscillates “on 










The angle to which M0 is tilted, known as the flip angle, α is determined by the duration t and the 
strength of B0 
    𝛼 = 𝛾𝐵8𝑡      (2.11) 
A rotating system of reference is used to simplify the understanding of nuclear excitation. This  
coordinate system rotates around B0, or z, at the Larmor frequency of the nucleus of interest. In 
this rotating frame, the axes have the notation x’, y’, z’. Now, rather than a complex circular 
rotation, B1 apears as a simpler stationary force along x’.  
 
 
Figure 2-5. In the rotating frame of reference, the z-axis is parallel to magnet field B0 while the x’ and y’ 
axes rotate about the z-axis at the Larmor frequency.  
 
2.2.7 Relaxation 
Following the application of the radiofrequency (RF) pulse, the magnetisation will return to 
thermal equilibrium in a process known as relaxation. This consists of two separate processes 
occurring simultaneously, but at different rates; the recovery of longitudinal magnetisation Mz, 
and loss of transverse magnetisation Mxy. Each of these has its own time constant, which can be 
described by:  
   .Yb 0.0 = YcdYb(0)Ee       (2.12) 








where T1 is the time constant required to recover 63% of longitudinal relaxation following a 90° 
pulse. T2  the time taken to loose 63% of the transverse magnetisation following a 90° pulse. 
Following excitation, excited spins gradually return to their thermal equilibrium or Boltzman 
distribution. This process involves the release of energy, as the excess is lost in interactions 
between the spin and the molecular environment or lattice. The rate of this recovery can be given 
by:  
   Mh t = Mh 0 edj/Xe + Mh(1 − edj/Xe)   (2.14) 
Immediately following an excitation pulse, the spins in the xy plane are in phase. Spins will 
interact with one another, with local magnetic field variations, resulting in slight changes to the 
speed of precession. As a consequence, spins become gradually out of phase. This interaction 
will occur many times for each spin. This loss of phase results in loss of transverse 
magnetisation (Figure 2-6) 
 
 
Figure 2-6. Dephasing of spins in the xy plane following a 90° pulse. 
 
The dephasing that occurs solely due to spin-spin interactions is known as T2. It, unlike spin-
lattice relaxation, does not involve loss of energy (there is no change of energy states of spins, 
merely dephasing). The decay of transverse magnetisation due to T2 can be described as 
follows: 














However, the magnetic field fluctuations experienced by spins do not only include dipolar field 
variation resulting from spin-spin interactions. The external magnetic field B0 itself will not be 
completely homogenous. The lack of homogeneity will result in local magnetic field variations, as 
spins experience different local field strengths. This external inhomogeneity is added to the 
internal inhomogeneity, resulting in increased dephasing and shorter relaxation times. This 
observed Mxy relaxation is known as T9∗ and can be described using:  
   8EU∗ = 8EU + 𝛾∆𝐵-      (2.16) 
where γ∆B- indicates the effect of tissue susceptibility and static field inhomogeneities. The 
magnetisation lost to T9∗ can be recovered using a technique known as spin-echo is described 
below (Section 2.3.2). 
2.2.8 Relaxation Times in Biological Tissues 
Relaxation times in fluids and solids vary significantly. These variations are due to the fact that 
each nucleus has a changing magnetic environment, with interactions between the magnetic 
moments of nearby electrons, nuclei and molecules. A local field results that can be described 
using the spectral density function J (𝜔): 
   𝐽 𝜔 = qr8stUqrU      (2.17) 
Where τc is the correlation time, a value that represents the average time it takes one molecule 
to rotate by one radian. Anything that can allow faster rotation, such as molecule size, viscosity 
or temperature will result in shorter τc. The relationship between τc and relaxation rates for two 
protons is given by the Solomon-Bloembergen equations for proton-proton interaction: 
   𝑅8 = 8Ee = xℏyz9-{| {𝐽 𝜔 + 4𝐽 2𝜔 }    (2.18) 
   𝑅9 = 8EU = ℏyz9-{| {3𝐽 0 + 5𝐽 𝜔 + 2𝐽 𝜔 }   (2.19) 
where (r) is the distance between the spins. 
T1 times, therefore, will differ if the sample studied is in solid or liquid form. T1 is longer in solids 
than pure liquids. Also, if the correlation time is close to the Larmor frequency, this will allow 
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energy transitions to occur, resulting in shorter T1 times. This factor also means that T1  
will vary with field strength. 
From equation 2.19, it can be seen that T9≤	T8 as T2 relaxation contains the contribution from an 
additional low-frequency component relative to T1 relaxation. Considering spectral density, a 
rapidly tumbling molecule will experience a local magnetic field that averages out quickly. A 
molecule that tumbles more slowly will experience the field homogeneities for longer, and 
become more rapidly out of phase. In contrast to T1, T2 does not vary widely with field strength. 
The relaxation constants of different biological tissues will, therefore, depend on the state of 
mobility of the protons and molecules that contribute to the proton signal. In general, the protons 
in water play the most important role, as the body is made up predominantly of water. Pure 
liquids like CSF will have long T1 values and tissues with higher water contents will, in general, 
have longer T1 values. For example, the medulla of the kidney, with a higher water content, has a 
longer than the cortex (29). The protons in fat tumble close to the Larmor frequency, resulting in 




Figure 2-7. The precession and relaxation of the magnetisation after a 90◦ excitation as it relaxes in the 










2.2.9 Detection of the MR signal - Fourier Transform NMR  
Following an RF pulse, magnetisation is tilted into the transverse plane. The resulting 
magnetisation can be detected with tuned RF coils using Faraday’s principle. The oscillating 
signal will decay over time due to the transverse relaxation processes described above (Figure 
2-7). This signal is known as the free induction decay (FID) and can be described by 
FID = [sin ωot ] e-t/T2*     (2.20) 
The coils used to detect the signal are in the x and y planes, allowing the complex signal along 
both component s to be simultaneously detected: 
S = Sx + i Sy       (2,21) 
where S represents the signal detected and i represents the square root of -1. As described 
before, the signal will decay with T9∗. The two signals acquired are cosine and sine functions of 
the offset frequency Ω = ω- − ω. Following a short RF pulse creating flip angle θ, the 
magnetisation components for each plane after the pulse can be derived using the Bloch 
equation (Eq. 2.10) and are given by:  
   𝑀m 0 = 0 
   𝑀n 0 = 𝑀-𝑠𝑖𝑛𝜃 
   𝑀 0 = 𝑀-𝑐𝑜𝑠𝜃     (2.22) 
  
The spin then precesses around B0 and undergoes relaxation. Therefore, the magnetisation 
components after an excitation are:  
   𝑀 𝑡 = 𝑀-𝑐𝑜𝑠𝜃𝑒− e + 𝑀-(1 − 𝑒− e)              (2.23) 
 
2.3 Measurement of Relaxation Time Constants 
Knowledge of the time constants T1 and T2 or T9∗ is essential, as they will affect the signal 
obtained by magnetic resonance and the pulse sequence parameters used to study the sample. 
As such, there has been interest in measuring these since the earliest days of NMR (15, 30). For 
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hyperpolarised 13C experiments, the T1 value describes the rate of loss of measureable 
hyperpolarised signal. A longer T1 allows the signal of a hyperpolarised tracer to be studied in in-
vivo experiments. 
2.3.1 T1 Measurements  
The conventional methods to measure T1 include the inversion recovery experiment with an 
initial 180° inversion and the saturation recovery experiment with a 90° excitation pulse (Figure 
2-8). The inversion recovery sequence is the gold standard for the determination of T1 relaxation 
times (31). This time can be calculated using:  
   𝑀 𝑡 = 𝑀-(1 − 𝛼𝑒d e	)     (2.24) 
Where t is the inversion time (TI) for an inversion recovery experiment (180° pulse), or TR for a 
repetition time for a saturation recovery measurement (90° pulse). α = 2 for an inversion recovery 
measurement or α = 1 for a saturation recovery measurement. If the experiment is repeated with 
different TI/TR, different FIDs will be acquired. These can then be fitted using equation 2.24, 
allowing the calculation of T8. In general, the delay time between two consecutive excitations 
should be t≥5T1 to allow for at least 99% of signal recovery. The inversion recovery results in 
longer scan times as more time is needed for Mz to recover fully before another excitation can be 
performed. Using a saturation pulse rather than an inversion pulse (Figure 2-8) results in shorter 
repetition times (TR) as the recovery only occurs from 90º. The shorter TR significantly reduces 
the scan duration.  
 
Figure 2-8. T1 relaxation can be measured using the inversion recovery (180º/90º) or saturation recovery 
(90º/90º) method (A). Magnetisation relaxes to thermal equilibrium value M0 over time constant T1 Different 
tissues will relax at different rates. Using a variety of inversion times (TI), the recovery of M0 can be 

















2.3.2 T2 Measurements  
After RF excitation field inhomogeneities and spin-spin interactions will cause spins to precess at 
slightly different Larmor frequencies. These different precession frequencies result in a loss of 
phase coherence as described in equation 2.25. The spin echo method allows the separation of 
the effects of T2 and magnetic field inhomogeneity (32). In a spin echo sequence (Figure 2-9, 
Figure 2-10) the magnetisation is tipped to the transverse plane by a 90° pulse. The 
magnetisation begins to lose coherence in the transverse plane because of the processes 
described above. After a delay of TE/2 a 180° pulse is applied. Dephasing is reversed, causing 
the spins to come together following another a delay of TE/2 generating a spin echo. The echo 
time TE refers to the time taken from the 90° pulse to the echo generation. By measuring the 
signal from different TE experiments, T2 can be calculated by fitting the signal intensities as a 
function of TE to the following equation: 
   𝑀𝑥𝑦 𝑡 = 𝑀𝑥𝑦(0)𝑒−𝑇𝐸/𝑇2      (2.25) 
 
Figure 2-9. Above: A typical spin-echo experiment with a 90º and 180º pulse. Below: The decay of the 
transverse magnetisation with T9∗ can be seen, followed by the regeneration of the signal following the 180º 












Figure 2-10. Spin-echo Diagram. (A) A 90° pulse tilts the spins into the transverse plane. (B), (C) The spins 
progressively dephase in the first half of the echo time TE/2. This dephasing in the transverse plane has a 
time constant T9∗ A 180º pulse refocuses the magnetisation vectors. (D), (E) The spins rephase again over 
TE/2. (F) Following TE, the spins have rephased and an echo is formed. 
 
 
2.3.3 Look-Locker Method 
The multiple-readout method was developed by Look and Locker to overcome the necessity for a 
long relaxation period between inversion pulses (Figure 2-11) (33). Following an inversion pulse 
(to maximise the dynamic range from +1 to -1), a train of low-flip-angle readout pulses is used to 
sample the magnetisation as it relaxes exponentially toward equilibrium. A continuous acquisition 
of image data is necessary for this method. However, cardiac motion means that this method is 
unsuitable for cardiac studies. To address this issue, the modified Look-Locker inversion 





Figure 2-11. Look-Locker inversion recovery pulse sequence diagram. A nonselective 180° inversion pulse 
(π) is used, which is followed by multiple small flip angle pulses (α). These are separated by time (τ) and 
sample the longitudinal signal magnetisation as it recovers to steady state. μ = undisturbed recovery period. 
From (34), used with permission.  
 
 
2.3.4 Modified Look-Locker Inversion Recovery 
The MOLLI pulse sequence merges data from three consecutive inversion recovery (IR) 
experiments into one data set generating single-slice	 T1 maps of the myocardium (Figure 2-12) 
(35). The image acquisition is gated to the electrocardiogram (ECG). It generates high spatial 
resolution single-slice T1 maps (2.0 x 2.0 mm2 in-plane). The potential clinical use of MOLLI has 
been shown in patients with both acute and chronic myocardial infarction (36, 37). MOLLI uses 
non-segmented acquisitions of 150–200 msec for each raw image. This technique can generate 
good quality end-diastolic images for heart rates up to 100 beats per minute (38). This technique 
is not suitable for the high heart rates of small animals (200–600 beats per minute). The SALLI 
(Small Animal Look-Locker Inversion recovery) technique was developed to overcome this 





Figure 2-12. MOLLI pulse sequence. LL1 - signal is sampled at end diastole for three consecutive cardiac 
phases following an inversion pulse where magnetisation recovers with a time constant T1∗ solid line) 
following an inversion pulse. Next comes a period of relaxation, (dashed line) where magnetisation recovers 
with T1 (dashed line). Following this relaxation period, the signal is again sampled for three (LL2) heartbeats 
with another relaxation period, before the final acquisition of data for four heartbeats (LL3). Imaging occurs 
within a single breath hold, and the data is regrouped into a merged imaged set according to the T1. From 




SALLI uses a segmented, ECG-gated, inversion recovery prepared Look-Locker–type pulse 
sequence to generate a data set. This data set can be used to reconstruct T1 maps, cine images, 
and inversion recovery images. A segmented approach allows the acquisition of T1 maps at end-
diastole at high heart rates. Acquisition times are increased to allow this, with the additional time 
is used to generate cine and inversion recovery images. Temporal undersampling and radial 
non-balanced steady-state free precession are used to enable an acceleration of data acquisition 
and reduction of motion artefacts respectively. The technique is further explained in Figure 2-13 





Figure 2-13. SALLI pulse sequence of fully sampled data sets and reconstruction schemes. From (39), 
used with publisher’s permission. 
Top: SALLI pulse sequence. Following an inversion pulse, signal is sampled for consecutive cardiac phases 
and while magnetisation recovers with a time constant T8∗ (solid line) following an inversion pulse 
(acquisition duration - AD). Next comes a defined period of relaxation, (relaxation duration - RD) where 
magnetisation now recovers with T1 (dashed line). This process is repeated for each radial segmental 
acquisition. T8∗ refers to the readout induced deviation of the magnetisation recovery curve caused by the 
sampling of the magnetisation. 
A: T1 maps reconstruction. The raw data is reconstructed using pixel-wise nonlinear curve fitting with a 
correction for T8∗. 
B: IR-prepared image reconstruction. Images with predefined inversion times are reconstructed from the 
image data. 
C: Cine images reconstruction. Images are reconstructed from the data available after the time point where 







Figure 2-14. SALLI pulse sequence scheme with temporally undersampled data acquisition (top) and 
image reconstruction (A – C). From (39), used with publisher’s permission. 
Top: Data for each radial segment are acquired every second phase of one heart cycle (for a temporal 
undersampling factor of two). Image acquisition is reversed in the following heart cycle. 
A. T1 maps are generated by combining data from neighbouring phases. 
B. IR-prepared images are generated in the same fashion 
C. Data from neighbouring heart cycles are combined, providing full data sets that can offer the same 




2.4 Chemical Shift 
Nuclei within the same molecule can have individual chemical environments (8) which will affect 
the resonance frequency 𝜔 of the nucleus. The distribution of electrons around the same type of 
nucleus (e.g. 1H, 13C) will vary because of local factors, such as binding partners, bond lengths, 
and the angles between bonds. These electrons will interact with the local magnetic field. 
Electrons, having an opposite charge to the proton, will precess about 𝐵- in the opposite 
direction. They will, therefore, induce an additional local magnetic moment at the nucleus 
shielding the external field B0  (Figure 2-15).  
 
 
Figure 2-15. The secondary magnetic field generated by the electrons “shields” the nucleus from the effects 
of the external magnetic field.  
 
The actual magnetic field experienced by the nucleus can be described by the shielding constant 
σ:  
    𝐵 = 𝐵-(1 − 𝜎)      (2.26) 
σ is a dimensionless constant that represents the difference between local and external magnetic 
fields. σ will differ depending on the arrangement of electrons around the nucleus in question. 
The actual Larmor frequency, therefore, reflects the real magnetic field experienced by the 








   𝜔0 = 𝛾𝐵0(1 − 𝜎)     (2.27) 
In practice, the absolute value of the change in frequency cannot be easily measured. The 
resonance frequency 𝜔 is then compared to that of a standard compound 𝜔𝑟𝑒𝑓.  
    𝛿 = tdtt ×10x      (2.28) 
This chemical shift δ provides information how atoms are bound within a molecule and is 
expressed in parts per million (ppm). The shifts in ppm are hence independent of magnetic field 
strength. 
2.5 Spectroscopy  
2.5.1 Spatial Localisation 
The simplest way to localise a slice is to use an additional magnetic field with a spatial gradient 
(Figure 2-16). The gradient is generated by varying the strength of the magnetic field along an 
axis of interest. When RF excitation with a given bandwidth is performed, only the spins fulfilling 
the resonance condition will be excited. The spin frequency ω of a particular nucleus with a 
position x in a sample is:  
    𝜔 𝑥 = 𝛾(𝐵- + 𝐺m𝑥)     (2.29) 
where γB- is the Larmor frequency ω0. The gradient G allows the selection of a slice 
perpendicular to that gradient. At the centre of the gradient x will equal 0, and the spins will 
resonate at the Larmor frequency. The slice position is determined by the centre frequency of the 
RF pulse (Figure 2-16). For a bandwidth of frequencies ∆ω, the spatial displacement ∆x of the 
acquired signal is given by: 
    Δ𝑥 = Δ𝜔/(𝛾𝐺m)      (2.30)  





Figure 2-16. Slice selection using magnetic field gradients. The variation in magnetic field strength across 
the field of view results in a corresponding change in the resonance frequencies. Therefore, a slice along an 
axis can be selectively excited. The position and thickness of this slice can be varied using the strength of 
the gradient and the radio-frequency offset.  
 
 
2.5.2 Single Voxel Spectroscopy 
There are a number of different techniques for signal localisation in MR spectroscopy, including 
the stimulated echo acquisition mode (STEAM) (40) and point-resolved spectroscopy (PRESS) 
(41) (Figure 2-17) Chemical-shift-selective (CHESS) pulses are applied to suppress the 
unwanted water signal. Both STEAM and PRESS involve the use of 3 slice selective RF pulses 
to select a voxel. The size, shape and location of the voxel can be adjusted (Figure 2-17). 
 
Figure 2-17. Single-voxel localization techniques. (A) Slice-selective RF pulses in the x, y and z-directions 
will result in a central voxel of interest. (B) The STEAM sequence consists of three orthogonal 90° slice 
selective pulses (C). The PRESS sequence is a double spin echo sequence, with orthogonal slice pulses of 
90°, 180°, 180°. 
 
 
In the case of STEAM, three orthogonal 90° slice selective pulses are used. The stimulated echo 






























spoiler gradient to dephase the magnetisation in the xy plane. The second 90° pulse rotates the 
magnetisation at the intersection of the two slices with the z-axis, thereby allowing the 
magnetisation to be “stored”. A spoiler pulse is used to eliminate the transverse component, 
leaving only magnetisation along the z-axis. The third 90° pulse tips this magnetisation back into 
the transverse plane where it refocuses to generate the simulated echo. The stimulated echo 
loses half the available equilibrium magnetisation due to the isotropic distribution of the spin 
following the 1st pulse. The TE of this stimulated echo is twice the time interval between the 1st 
and 2nd 90° pulses.  
 
Figure 2-18. Anatomic 1H images are used for localizing the volume of interest (VOI). Localization is 
achieved by sequential selection of three orthogonal slices. The size and location of VOI can be easily 
controlled.  
 
PRESS is based on the spin-echo technique. Three pulses are used, a 90° pulse to generate 
transverse magnetisation, a 180° pulse to refocus this magnetisation, and a second refocusing 
180° pulse. The voxel of interest is the volume that experiences all three pulses. This technique 
generates a signal twice the amplitude of the stimulated echo, and, therefore, has a higher signal 









magnetisation. PRESS can be used for both long and short T applications. The choice of TE 
plays a significant role in the spectrum detected. A longer T will select the metabolites with 
longer T2, whereas a shorter TE will generate more peaks, with a resultant more complex 
spectrum for interpretation. 
2.5.3 Magnetic Resonance Spectroscopic Imaging  
Similar to MRI, magnetic resonance spectroscopic imaging (MRSI) uses frequency and phase 
encoding to localize the signal (42). The use of slice selection and spatial encoding techniques in 
MRSI was first demonstrated by Brown et al. in 1982 (43). A volume of interest (VOI) is selected 
with the use of magnetic field gradients (Figure 2-18). The VOI selection is followed by a phase 
gradient in 1, 2 or 3 dimensions. These gradients are then turned off, and the signal is acquired 
as a FID or spin echo. The process is repeated to generate a full data set of phase encoded 
signals, which are then Fourier transformed to generate spatial and frequency data.  
The MRSI technique using phase-encoding is time-inefficient as for an n-dimensional image, with 
m pixels in each direction, the acquisition will require n x m phase-encode experiments. To avoid 
T1 weighting, a TR of greater than five times the T1 will be needed. Therefore, the practical 
resolution of this technique is limited.  
2.5.4 Echo Planar Spectroscopic Imaging 
An important step towards rapid MR imaging was the introduction of echo-planar imaging (EPI), 
first proposed by Mansfield in 1977 (44). This development led to the first human images 
published by the same group in 1983 (45). EPI is essentially the combination of two 1D 
localization methods, with frequency encoding in one direction and phase encoding in the other 
direction (Figure 2-19). The advantage of EPI is that it allows multiple lines of k-space to be filled 
following each RF pulse. If k-space is completely filled following a single excitation, the technique 
is called “single-shot” EPI. In this case, the time required to fill k-space will equal 1 TR. As the k-
space is being sampled, the echoes will decay with T9∗ . If the acquisition time is much greater 
than T9∗  the signal will have decreased considerably from the start of the acquisition to the finish, 
leading to different weighting across k-space. To ensure homogenous k-space weighting, the 
entire acquisition must occur very rapidly, placing significant demands on the gradients of the MR 






Figure 2-19. (A) Gradient-echo EPI sequence. Sampling is started at the edge of k-space with the aid of 
gradients in the x and y-direction. The blue and lines represent the frequency encoding gradients where 
signal is acquired while the red lines represent the phase encoding blips. The frequency-encoding gradient 
is then reversed, leading to the generation and acquisition of the first gradient-echo (1). A phase encoding 
gradient alters the k-space position and then the frequency-encoding gradient is again reversed, leading to 
another gradient-echo (2). This back and forth continues until all of k-space is filled. 
 
Spectroscopic imaging requires not only spatial but also spectral information to be encoded. In 
1984, Mansfield proposed a solution for rapid spectroscopic imaging, echo-planar spectroscopic 
imaging (EPSI) (46). Hardware limitations, however, meant that this method was first 

































Figure 2-20. In echo-planar spectroscopic imaging (EPSI), the signal is acquired during an oscillating 
gradient waveform 
 
The periodic inversion of the gradient lobe during the readout enables the encoding of 
spectroscopic signals as a single k-space line is repeatedly acquired as shown in Figure 2-20. 
This “zig-zag” provides spatial and spectral encoding. EPSI methods have been developed to 
allow regional assessment of cardiac metabolites and triglycerides in vivo (48). 
2.6 Hyperpolarisation 
Hyperpolarisation refers to the nuclear spin polarisation of a material far beyond thermal 
equilibrium conditions. Figure 2-21 is a simplified illustration of the results of hyperpolarisation on 
the magnetic moments of a sample.  A number of techniques to increase the polarisation of a 
material exist. These include "brute force" methods (49), optical pumping of noble gases (50), 
para-hydrogen induced polarisation (51) and dynamic nuclear polarisation (DNP) (52). The 
enormous increases in signal provided by DNP offer great promise in the study of biological 
processes. 
DNP can provide an increase in sensitivity of up to 10,000-100,000-fold. Potential advantages of 
hyperpolarisation include; decreased time required to observe a metabolite concentration change 










Figure 2-21. (A) illustrates the random nature of nuclear magnetic moments μ. (B) shows the alignment of 
the z-component of magnetic moments spin either with or against the external magnetic field (B0) at thermal 
equilibrium. (C) illustrates the effect of hyperpolarisation, where the majority of magnetic moments to align 
with B-. 
 
2.7 Dynamic Nuclear Polarisation  
DNP transfers the spin polarisation from electrons to nuclei (55-59). This transfer is carried out 
by first adding a small amount of a radical with unpaired electrons to a sample containing the 
molecule of interest. The sample is frozen to liquid helium temperatures (1 ± 0.3 K) and placed in 
a high magnetic field. At these temperatures, the electron spin polarisation approaches 100%. 
The sample is then irradiated with a continuous microwave frequency ω, a frequency that is close 
to the Larmor frequency of the electron spins ω. This radiation saturates the electron spin 
resonance (ESR) line of the unpaired electrons of stable radicals. Accordingly, the polarisation of 
the electrons can be transferred to the nuclei. Once an electron has transferred its polarisation, it 
returns to thermal equilibrium with a time T1e, and can then polarise another nucleus. This 
process is known as the solid effect and requires high microwave power. Electron relaxation 
must occur faster than the T1N of the nucleus for hyperpolarisation to proceed.  
Other methods of hyperpolarisation include thermal mixing, which can take place with, or instead 
of the solid effect. Thermal mixing is a two-step effect, requiring less microwave energy than the 
solid effect. It involves two electrons and one nucleus. Firstly, the spin of one electron is flipped; 
this is followed by the flipping of two electrons of opposite sign, which then induces a flip in the 
nuclear spin. Thermal mixing requires a higher concentration of free electrons to allow coupling 
to occur between them and the nucleus of interest. Freezing the sample into a glassy state, using 











2.8 Dissolution DNP  
A dissolution DNP experiment is a three-step process; polarisation via DNP by microwave 
irradiation at low temperature, dissolution in a hot solvent and, finally, sample injection and data 
acquisition (53).  
The molecule of interest (most commonly 13C labelled pyruvate) is mixed with a source of free 
electrons provided by radicals. The mixture is cooled, placed in a magnetic field and pumped to 
low pressure to bring the temperature to approximately 1K (53). The magnetic field is used to 
polarise the electrons. With microwave radiation applied at a particular frequency, this high 
polarisation is transferred to the nuclei of interest. The process can take between 30 and 60 
minutes depending on the T1 of the sample in the solid state. 
The sample must be rapidly warmed to allow its use in vivo. The hyperpolarised molecule sample 
is melted with a heated solution and shuttled out of the system using high-pressure helium gas. 
The solution can then injected into the subject of interest, and its downstream metabolites can be 
differentiated from each other on the basis of their chemical shifts. 
Typical polarisation levels produced with [1-13C] pyruvate range from 20-40%. This polarisation 
decays with the T1  of the molecule. The T1 value varies with the molecule studied but is typically 
1-2 minutes for molecules of small weight. The short T1 value means that the solution must be 
used quickly after being generated.  
Hyperpolarised 13C MR studies have mainly used the molecules [1-13C] pyruvate, [2-13C] 
pyruvate, and 13C-bicarbonate as they polarise efficiently, retain hyperpolarisation for a relatively 
long time, and are rapidly metabolised via critical enzymes in the heart. It has been found that 
13C labelled carbonyl positions are of particular interest as the T1 is about 30-50 seconds. T1  
times of molecules of interest in biomedical imaging are shown in Table 2-2.  
Pyruvate is a key substrate for many metabolic pathways. Its role as an intermediary can be 
clearly seen in the simplified Figure 2-22. In the myocardial cells, pyruvate can be metabolised to 
lactate, alanine, and CO2. Following combination with water to form carbonic acid, the CO2 




Figure 2-22. Simplified diagram indicating the role of pyruvate as the end product of glycolysis, showing its 
key position between glycolysis and the tricyclic acid (TCA) cycle. Some of the products measured by 
hyperpolarised 13C DNP imaging, including lactate and bicarbonate (HCO3-) can also be seen. 
 
DNP allows the detection of metabolites present at very low concentrations, undetectable by 
conventional NMR. Additionally it enables the observation of fast metabolic processes in real-
time and in-vivo after infusion of hyperpolarised 13C labelled biomolecules (54).  
Unlike in conventional MR, where relaxation increases the longitudinal magnetisation, T8 
relaxation in hyperpolarised experiments involves decay of magnetisation to normal Boltzmann 
polarisation levels. This fact means that conventional spin echo sequences are of little use, as 
hyperpolarisation does not relax back to its initial magnetisation following a single 90° RF pulse, 
rather it remains at zero. For this reason, multiple low flip angle acquisitions are typically 






Table 2-2. Longitudinal relaxation times T1 of 13C labelled metabolites of interest for in vivo DNP studies. 
Adapted, with permission, from (26). 
 
2.9 Dynamic 13C NMR Spectroscopy 
Rapid acquisitions are needed to measure the metabolic information before the hyperpolarisation 
has decayed. A variety of methods has been used to date. Some of the earliest images 
generated used MRSI to image the metabolic changes following myocardial ischemia in a pig 
model (55). However, the limitations of this method include poor resolution, a lack of dynamic 
acquisition, and the length of acquisition time. Alternatives to overcome some of these issues 
include EPSI (56) (1.5.3.1) and fast spiral MRSI (57). 
Besides MRSI and EPSI, the process of spectral encoding can also be addressed using spatial-
spectral (SPSP) excitation in conjunction with EPI readouts (58). The sparse spectra (i.e., 
pyruvate, lactate, alanine, and bicarbonate) following the injection of hyperpolarised 13C-pyruvate 
are well suited to the SPSP technique (59, 60). SPSP pulses are applied in the frequency and 
slice-selective direction simultaneously. Changing the excitation frequency will result in different 
metabolites being encoded in an interleaved scheme. Each metabolite of interest can be excited 
with a particular flip angle. Selective excitation is of particular importance in hyperpolarised 
imaging. For example, following hyperpolarised pyruvate injection, the initial concentration of 
pyruvate will be much higher than that of its downstream metabolites – such as lactate or 
bicarbonate. A lower flip angle can be used for pyruvate, avoiding saturation while conserving 
polarisation. A higher flip angle is used for its downstream metabolites that are found in lower 
concentrations (60). Disadvantages of this approach include the long SPSP pulse required, and 
the inability for correction after the use of an incorrect excitation frequency. Minimum slice 
Metabolite    T1[s]  
[1-13C]sodium acetate 49 (11.7T); 50 (3T); 34 (3T) 
[1-13C]alanine 42 (3T); 29 (9.4T) 
[1-13C]bicarbonate  49 (11.7T); 34 (3T) 
[1-13C]pyruvic acid 67 (3T); 48 (11.7T); 44 (14.1T) 
[1,5-13C]citric acid 25 
[1-13C]lactate 45, 50.6 (3T); 32, 33.4 (14.1T) 
[1,1’-13C2]butyric anhydride 39,40 (14.1 T) 
[1,4-13C]fumaric acid 24 (9.4T); 29 (11.7T) 
13C -urea 44 (11.7T); 35 (14.1T) 
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thickness is limited by the minimum time between SPSP subpulses. However, modifications of 







(1) Zeeman, P. (1897). XXXII. On the influence of magnetism on the nature of the light 
emitted by a substance. Philosophical Magazine Series 5 43(262), 226-239. 
(2) Pauli, W., Jr. (1924). Zur Frage der theoretischen Deutung der Satelliten einiger 
Spektrallinien und ihrer Beeinflussung durch magnetische Felder. Naturwissenschaften 
12(37), 741-743. 
(3) Bloch, F., Hansen, W.W., and Packard, M. (1946). Nuclear Induction. Phys. Rev. 69(3-
4), 127-127. 
(4) Purcell, E.M., Pound, R.V., and Bloembergen, N. (1946). Nuclear Magnetic Resonance 
Absorption in Hydrogen Gas. Phys. Rev. 70(11-12), 986-987. 
(5) Knight, W.D. (1949). Nuclear Magnetic Resonance Shift in Metals. Phys. Rev. 76(8), 
1259-1260. 
(6) Meyer, L.H., Saika, A., and Gutowsky, H.S. (1953). Electron Distribution in Molecules. III. 
The Proton Magnetic Spectra of Simple Organic Groups1. J. Am. Chem. Soc. 75(18), 
4567-4573. 
(7) Proctor, W.G., and Yu, F.C. (1951). On the Nuclear Magnetic Moments of Several Stable 
Isotopes. Phys. Rev. 81(1), 20-30. 
(8) Proctor, W.G., and Yu, F.C. (1950). The Dependence of a Nuclear Magnetic Resonance 
Frequency upon Chemical Compound. Phys. Rev. 77(5), 717-717. 
(9) Dickinson, W.C. (1950). Dependence of the F19 Nuclear Resonance Position on 
Chemical Compound. Phys. Rev. 77(5), 736-737. 
(10) Shaw, T.M., and Elsken, R.H. (1950). Nuclear Magnetic Resonance Absorption in 
Hygroscopic Materials. J. of Chem. Phys.18(8), 1113-1114. 
(11) Moon, R.B., and Richards, J.H. (1973). Determination of intracellular pH by 31P 
magnetic resonance. J. Biol. Chem. 248(20), 7276-8. 
(12) Hoult, D.I., Busby, S.J., Gadian, D.G., Radda, G.K., Richards, R.E., and Seeley, P.J. 
(1974). Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 
252(5481), 285-7. 
(13) Digby, A. (2001). Wellcome witnesses to twentieth century medicine, vol. 2. Making the 
human body transparent: the impact of nuclear magnetic resonance and magnetic 
61 
 
resonance imaging. Research in general practice. Drugs in psychiatric practice. The 
MRC Common Cold Unit. Med. Hist. 45(1), 137-138. 
(14) Matwiyoff, N.A., and Needham, T.E. (1972). Carbon-13 NMR spectroscopy of red blood 
cell suspensions. Biochem. Biophys. Res. Commun. 49(5), 1158-64. 
(15) Odeblad, E., and Lindstrom, G. (1955). Some preliminary observations on the proton 
magnetic resonance in biologic samples. Acta Radiol Suppl (Stockholm) 43, 469-76. 
(16) Odeblad, E. (1968). An NMR-Method for Determination of Ovulation. Acta Obstet. 
Gynecol. Scand. 47(S8), 39-47. 
(17) Damadian, R., Zaner, K., Hor, D., and DiMaio, T. (1974). Human tumors detected by 
nuclear magnetic resonance. Proc. Natl. Acad. Sci. U. S. A. 71(4), 1471-3. 
(18) Lauterbur, P.C. (1973). Image Formation by Induced Local Interactions: Examples 
Employing Nuclear Magnetic Resonance. Nature 242(5394), 190-191. 
(19) Mansfield, P., and Grannell, P.K. (1973). NMR 'diffraction' in solids? J.  Phys. C: Solid 
State 6(22), L422. 
(20) Kumar, A., Welti, D., and Ernst, R.R. (1975). NMR Fourier zeugmatography. J. Magn 
Reson.  (1969) 18(1), 69-83. 
(21) Reiser, M. (2008). Magnetic resonance tomography (Heidelberg: Springer). 
(22) Balc, M. (2005). Basic  p1 sH- and  p13 sC-NMR spectroscopy (Amsterdam: Elsevier). 
(23) Graaf, R.A.d. (2007). In vivo NMR spectroscopy principles and techniques, 2nd edn 
(Chichester: Wiley). 
(24) Harris, R. (1986). Nuclear magnetic resonance spectroscopy [Online]. Harlow: Longman 
Scientific Technical.  
(25) Mitchell, H.H., Hamilton, T.S., Steggerda, F.R., and Bean, H.W. (1945). The Chemical 
Composition of the Adult Human Body and its bearing on the Biochemistry of Growth. J. 
Biol. Chem. 158(3), 625-637. 
(26) Keshari, K.R., and Wilson, D.M. (2014). Chemistry and biochemistry of 13C 
hyperpolarized magnetic resonance using dynamic nuclear polarization. Chem. Soc. 
Rev. 43(5), 1627-59. 
(27) Bloch, F., Hansen, W.W., and Packard, M. (1946). The Nuclear Induction Experiment. 
Phys. Rev. 70(7-8), 474-485. 
(28) Bloch, F. (1946). Nuclear Induction. Phys. Rev. 70(7-8), 460-474. 
62 
 
(29) Bazelaire, C.M.J.d., Duhamel, G.D., Rofsky, N.M., and Alsop, D.C. (2004). MR Imaging 
Relaxation Times of Abdominal and Pelvic Tissues Measured in Vivo at 3.0 T: 
Preliminary Results. Radiology 230(3), 652-659. 
(30) Huggert, A., and Odeblad, E. (1959). Proton magnetic resonance studies of some 
tissues and fluids of the eye. Acta Radiol. 51(5), 385-92. 
(31) Moon, J.C., Messroghli, D.R., Kellman, P., Piechnik, S.K., Robson, M.D., Ugander, M., 
Gatehouse, P.D., Arai, A.E., Friedrich, M.G., Neubauer, S., et al. (2013). Myocardial T1 
mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic 
Resonance (SCMR) and CMR Working Group of the European Society of Cardiology 
consensus statement. J. Cardiovasc. Magn. Reson. 15, 92. 
(32) Hahn, E.L. (1950). Spin Echoes. Phys. Rev. 80(4), 580-594. 
(33) Look, D.C., and Locker, D.R. (1970). Time Saving in Measurement of NMR and EPR 
Relaxation Times. Rev. Sci. Instrum. 41(2), 250-251. 
(34) Henderson, E., McKinnon, G., Lee, T.Y., and Rutt, B.K. (1999). A fast 3D look-locker 
method for volumetric T1 mapping. Magn. Reson. Imaging 17(8), 1163-71. 
(35) Messroghli, D.R., Radjenovic, A., Kozerke, S., Higgins, D.M., Sivananthan, M.U., and 
Ridgway, J.P. (2004). Modified Look-Locker inversion recovery (MOLLI) for high-
resolution T1 mapping of the heart. Magn. Reson. Med. 52(1), 141-6. 
(36) Messroghli, D.R., Walters, K., Plein, S., Sparrow, P., Friedrich, M.G., Ridgway, J.P., and 
Sivananthan, M.U. (2007). Myocardial T1 mapping: application to patients with acute and 
chronic myocardial infarction. Magn. Reson. Med. 58(1), 34-40. 
(37) Messroghli, D.R., Niendorf, T., Schulz-Menger, J., Dietz, R., and Friedrich, M.G. (2003). 
T1 mapping in patients with acute myocardial infarction. J. Cardiovasc. Magn. Reson. 
5(2), 353-9. 
(38) Messroghli, D.R., Plein, S., Higgins, D.M., Walters, K., Jones, T.R., Ridgway, J.P., and 
Sivananthan, M.U. (2006). Human myocardium: single-breath-hold MR T1 mapping with 
high spatial resolution--reproducibility study. Radiology 238(3), 1004-12. 
(39) Messroghli, D.R., Nordmeyer, S., Buehrer, M., Kozerke, S., Dietrich, T., Kaschina, E., 
Becher, P.M., Hucko, T., Berger, F., Klein, C., et al. (2011). Small animal Look-Locker 
inversion recovery (SALLI) for simultaneous generation of cardiac T1 maps and cine and 
63 
 
inversion recovery-prepared images at high heart rates: initial experience. Radiology 
261(1), 258-65. 
(40) Frahm, J., Merboldt, K.-D., and Hänicke, W. (1987). Localized proton spectroscopy using 
stimulated echoes. Journal of Magnetic Resonance (1969) 72(3), 502-508. 
(41) Bottomley, P.A. (1987). Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. 
Acad. Sci. 508, 333-48. 
(42) Keevil, S.F. (2006). Spatial localization in nuclear magnetic resonance spectroscopy. 
Phys. Med. Biol. 51(16), R579-636. 
(43) Brown, T.R., Kincaid, B.M., and Ugurbil, K. (1982). NMR chemical shift imaging in three 
dimensions. Proc. Natl. Acad. Sci. U. S. A. 79(11), 3523-6. 
(44) Mansfield, P. (1977). Multi-planar image formation using NMR spin echoes. J.  Phys. C: 
Solid State 10(3), L55. 
(45) Rzedzian, R., Chapman, B., Mansfield, P., Coupland, R.E., Doyle, M., Chrispin, A., 
Guilfoyle, D., and Small, P. (1983). Real-time nuclear magnetic resonance clinical 
imaging in paediatrics. Lancet 2(8362), 1281-2. 
(46) Mansfield, P. (1984). Spatial mapping of the chemical shift in NMR. Magn. Reson. Med. 
1(3), 370-86. 
(47) Posse, S., Dager, S.R., Richards, T.L., Yuan, C., Ogg, R., Artru, A.A., Muller-Gartner, 
H.W., and Hayes, C. (1997). In vivo measurement of regional brain metabolic response 
to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging 
(PEPSI). Magn. Reson. Med. 37(6), 858-65. 
(48) Weiss, K., Martini, N., Boesiger, P., and Kozerke, S. (2012). Metabolic MR imaging of 
regional triglyceride and creatine content in the human heart. Magn. Reson. Med. 68(6), 
1696-704. 
(49) Johnson, R., Paulson, D., Giffard, R., and Wheatley, J. (1973). Bulk nuclear polarization 
of solid3He. J. Low Temp. Phys. 10(1-2), 35-58. 
(50) Happer, W. (1972). Optical Pumping. Rev. Mod. Phys. 44(2), 169-249. 
(51) Bowers, C.R., and Weitekamp, D.P. (1987). Parahydrogen and synthesis allow 
dramatically enhanced nuclear alignment. J. Am. Chem. Soc. 109(18), 5541-5542. 
(52) Abragam, A., and Goldman, M. (1978). Principles of dynamic nuclear polarisation. Rep. 
Prog. Phys 41(3), 395. 
64 
 
(53) Ardenkjaer-Larsen, J.H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M.H., 
Servin, R., Thaning, M., and Golman, K. (2003). Increase in signal-to-noise ratio of > 
10,000 times in liquid-state NMR. Proc. Natl. Acad. Sci. U. S. A. 100(18), 10158-63. 
(54) Golman, K., in 't Zandt, R., and Thaning, M. (2006). Real-time metabolic imaging. Proc. 
Natl. Acad. Sci. U. S. A. 103(30), 11270-5. 
(55) Golman, K., Petersson, J.S., Magnusson, P., Johansson, E., Akeson, P., Chai, C.M., 
Hansson, G., and Mansson, S. (2008). Cardiac metabolism measured noninvasively by 
hyperpolarized 13C MRI. Magn. Reson. Med. 59(5), 1005-13. 
(56) Yen, Y.F., Kohler, S.J., Chen, A.P., Tropp, J., Bok, R., Wolber, J., Albers, M.J., Gram, 
K.A., Zierhut, M.L., Park, I., et al. (2009). Imaging considerations for in vivo 13C 
metabolic mapping using hyperpolarized 13C-pyruvate. Magn. Reson. Med. 62(1), 1-10. 
(57) Mayer, D., Levin, Y.S., Hurd, R.E., Glover, G.H., and Spielman, D.M. (2006). Fast 
metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C 
imaging. Magn. Reson. Med. 56(4), 932-7. 
(58) Meyer, C.H., Pauly, J.M., Macovski, A., and Nishimura, D.G. (1990). Simultaneous 
spatial and spectral selective excitation. Magn. Reson. Med. 15(2), 287-304. 
(59) Cunningham, C.H., Chen, A.P., Lustig, M., Hargreaves, B.A., Lupo, J., Xu, D., 
Kurhanewicz, J., Hurd, R.E., Pauly, J.M., Nelson, S.J., et al. (2008). Pulse sequence for 
dynamic volumetric imaging of hyperpolarized metabolic products. J. Magn. Reson. 
193(1), 139-46. 
(60) Lau, A.Z., Chen, A.P., Hurd, R.E., and Cunningham, C.H. (2011). Spectral-spatial 
excitation for rapid imaging of DNP compounds. NMR Biomed. 24(8), 988-96. 
(61) Weiss, K., Sigfridsson, A., Wissmann, L., Busch, J., Batel, M., Krajewski, M., Ernst, M., 
and Kozerke, S. (2013). Accelerating hyperpolarized metabolic imaging of the heart by 





Chapter 3 -  T1 Mapping in Ischemic Heart Disease 
3.1 Abstract 
Disease processes can change the quantity and form of water in tissues. Research into T1 
mapping has primarily been focused on the study of cardiomyopathies, but T1 mapping also 
shows potential in the study of ischaemic heart disease. In fact, the first cardiac T1 maps were 
used to characterise myocardial infarction in the 1980s. Robust high-resolution myocardial T1 
mapping is now available for use as a clinical tool. This quantitative technique is simple to 
perform and analyse, minimally subjective, and highly reproducible. This chapter aims to 
summarise the present state of research on the topic and to show the clinical potential of this 





Magnetic resonance imaging (MRI) is the gold standard imaging technique for cardiac anatomy 
and function. A unique feature of MRI is its ability to characterise tissue using proton relaxation 
times, T1, T2, and T9∗. These values are mostly dependent on the physical and chemical 
environments of water protons in tissue. Using conventional MRI techniques, higher signal 
intensity with either T1 weighted sequences using gadolinium contrast agents or T2 weighted 
techniques can detect myocardial infarction (MI) or focal oedema respectively. Unlike other 
imaging modalities, such as CT, signal intensity in CMR images is displayed on an arbitrary 
scale. This property means that signals cannot be quantified or compared between subjects or 
follow-up examinations in the same individual. Visualization of pathology depends on a contrast 
existing between “normal” and “abnormal” myocardium. T1 weighted sequences provide the 
basis for late gadolinium enhancement (LGE) imaging that is now universally used in the 
detection of MI, the focal lesions of myocarditis and myocardial fibrosis in cardiomyopathies. 
T1 values are a reflection of the composition of individual tissues, with each tissue type having a 
normal range. T1 values can alter in the presence of disease, and this difference can be used to 
study and diagnose tissue pathology (2). In fact, some of the earliest work on MRI was driven by 
a belief that cancerous tissues could be distinguished from healthy tissues on the basis of their 
relaxations times (3). T1 reflects the mobility of nuclei (predominantly protons) and how they are 
bound within macromolecules. Therefore, it can be used to study macromolecular content, water 
binding and water content. For example, muscle has an intermediate value but with inflammation, 
water content increases and is matched by an increase in T1. 
When T1 is measured on a pixel-by-pixel basis, the resulting T1 values can be visualized as a T1 
map. In this map, the signal intensity of each pixel reflects the absolute T1 value of the underlying 
voxel. The interest in absolute quantification of T1 values in a clinical setting has risen recently. 
Over the last few years, a number of sequences have been developed which allow robust high-




3.3 Historical Background 
T1 quantification has been the basis for diagnostic methods since the beginning of magnetic 
resonance imaging in the early 1970s. The initial studies looking at changes in T1 in the heart 
were performed in vitro using samples from dog hearts (6). These showed that T1 increased with 
ischemia and that the magnitude of increase was related to the duration and severity of ischemia. 
In-vivo studies then demonstrated increases in T1 and T2 with infarction. The first studies to 
quantify myocardial T1 in humans with recent myocardial infarction (MI) also detected increased 
T1. These were also the first to present their findings as a map of the T1 values of the heart (7). T1 
was found to increase within the first hour of ischemia (8), reach its peak in patients with ST-
elevation myocardial infarction (STEMI) between days 8-14, before gradually returning to 
baseline (9). 
Following these early studies, specific techniques were developed to exploit these changes in 
tissue oedema. The short-inversion-time inversion recovery (STIR) magnetic resonance imaging 
pulse sequence, which generates high contrast from both T1 and T2 prolongation in the presence 
of water, is widely used for the detection of myocardial oedema in myocarditis (10), rejection in 
cardiac transplant (11), and acute MI (12). 
Ex-vivo measurements of T1 are usually based on inversion recovery sequences, requiring an 
interval of at least five times the T1 to allow for adequate recovery. This technique could be used 
for the first investigations into myocardial relaxation at very low field strengths (0.08T). At these 
very low field strengths, T1 is short (305 ms), and acquisition schemes can easily be fitted into 
the cardiac cycle (7, 9). As field strength increased to 1.5T, myocardial T1 increased to 
approximately 1000 ms, which exceeds cardiac cycle length in most patients. As a consequence, 
conventional acquisition schemes could not be confined to single cardiac cycles and required 
long acquisition times. The long acquisition times prevented their use as breath-hold techniques 
in clinical routine. Cardiac motion meant that alternative methods, such as the Look-Locker 
described above, were unsuitable for imaging the heart. 
T1 quantification in ischemic heart disease can be divided into native and post-contrast 
applications. Native T1 values in this setting are a reflection of the composite water signal from 
interstitium and myocytes, and, therefore, reflect changes in water content. As standard 
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gadolinium contrast agents are extravascular and extracellular, changes in T1 following contrast 
administration reflect gadolinium concentration in the extravascular compartment. These 
changes can then be used to estimate extracellular volume (ECV). 
  
3.4 Native Myocardial applications 
3.4.1 Myocardial Oedema  
To understand the changes occurring in myocardial relaxation values, we need to understand the 
response of the heart to injury. Myocardial injury is characterised by cellular oedema (13). In 
healthy myocardium, water balance is tightly regulated by cell membrane function, Starling 
filtration and lymphatic drainage. Intracellular water accounts for 79% of total water or about 
380ml/100g of dry tissue and varies little between individuals or species (14). As myocardial 
water balance is an energy requiring process, myocardial ischemia will result in failure of the 
active processes of cell volume regulation. The earliest studies looking at T1 values in myocardial 
ischemia came from the knowledge that ischemia results in oedema (15). In fact, the increasing 
amounts of water present after reflow have been shown to correlate with increased myocardial 
injury in an animal model (16). 
Myocardial oedema occurs within 15 minutes of coronary occlusion (17). Myocardial water 
reaches its peak in the first 1-2 hours after onset of ischemia (18) and is caused by dysfunction 
of the complex processes that regulate both intra- and intercellular myocardial water balance. 
Initially, there is a local intracellular increase in the products of anaerobic metabolism, such as 
lactate and inorganic phosphates (19). The increased osmotic load draws water into the 
intracellular space (17).This initial increase in water is limited by the reduction in blood supply 
and the limited amount of extracellular water. 
The alterations in cell membrane function can be simplified into three stages (20). Initially there is 
inhibition of the Na+/K+ pump, resulting in an influx of water as it follows the increased 
intracellular Na+. The second stage involves the sarcolemmal transport systems, again leading to 
an increase in intracellular water. Finally, physical disruption of the cell membrane occurs, and 
breakdown of the water and ion equilibrium between the interior and exterior of the cell. 
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Reperfusion can worsen myocardial oedema, but the degree of oedema is predominantly 
determined by the duration and severity of the preceding ischemic episode (21). The increased 
oedema is caused by a reactive hyperaemia and osmotic changes. Following the opening of an 
occluded coronary artery, blood flow to ischemic myocardium significantly increases. There is a 
localised increase in cellular osmolality as high energy phosphates, and macromolecules are 
broken down (22). These products diffuse into extracellular spaces but, intracellular osmolality 
remains increased (22). On reperfusion, the hyperosmolar myocardial cells absorb extra fluid 
across this osmotic gradient to return the osmolarity of the intracellular environment to normal. 
The time before cell death will vary on the degree of ischemia, whether there is absolute 
cessation or merely reduced blood flow, the presence of collateral blood supply, and the duration 
of ischemia. From the processes described above, it can be seen that prolonged ischemia will 
result in a breakdown of the active processes maintaining cellular homeostasis, with the final 
stage being the breakdown of myocardial cell walls. Brief episodes of ischemia are tolerated by 
the myocardial cells. In general, coronary occlusions of up to 15 minutes is thought to be 
associated with reversible injury, with occlusion of longer duration resulting in myocardial 
infarction. 
  
3.4.2 T1 Changes in Myocardial Infarction 
Changes in T1 can be used to detect acute MI with high sensitivity and specificity (23-25). As of 
yet there is no cut-off T1 value to distinguish infarcted myocardium from the surrounding 
oedematous myocardium; however previous studies have demonstrated high accuracy using 
three (23) and two (24) standard deviations above mean values. Whereas most studies have 
focused on patients with ST-elevation myocardial infarction (STEMI), T1 mapping can also 
identify infarction in patients with non-STEMI (24). There is a progression in T1 from healthy 
myocardium to that of maximal injury, a finding similar to the peri-infarct zone described in 
studies studying MI with contrast agents (26), or the wavefront phenomenon In acute MI (27). T1 
increases are more pronounced in the myocardium that will become infarcted than in 
myocardium that will be salvaged by reperfusion (28). Following reperfusion, T1 increases further 




Figure 3-1. (a) Short axis STIR image in 52-year-old male six days post anterior STEMI with localised 
hyperintensity indicating acute oedema (arrows). (b) Corresponding T1 map demonstrates a similar area of 
injury; however there is a zone with a range of increased T1  (arrows) reflecting the increasing severity of 
injury from epicardium to endocardium. 
 
In chronic MI, T1 values are higher than normal myocardium, but do not reach the levels of acute 
MI (23). There is replacement of myocardial cells by scarring or fibrosis with an increase in 
extracellular collagen. Importantly, there is no oedema, as this has resolved in the initial weeks 
after MI. These subtle differences in T1 in chronic infarction do not allow reliable discrimination of 
acute from chronic myocardial without the use of gadolinium contrast (23). In some areas of 
chronic MI areas of lipomatous metaplasia can be seen, particularly when T1 weighted 
sequences are used (29). As fat has a T1 value much lower than myocardium (230-350 ms), 
intramyocardial fat can be easily identified byT1 mapping (30). 
Elevated myocardial water content also results in increased T2. T2 weighted imaging has been 
used for oedema imaging since the first papers demonstrating T2 prolongation in MI in dogs (31) 
and humans (32). T2 based imaging techniques have been used in acute MI, (12) myocarditis, 
(10) sarcoidosis, (33) and in cardiac transplant rejection (34). A difficulty with this technique is the 
need for a homogenous magnetic field, as the increase in T2 associated with oedema in acute MI 
is relatively small - in the order of 15-20 ms (8). The STIR sequence, a technique that uses 
changes in both T1 and T2 to obtain contrast, is commonly used to identify areas of hyperintense 
signal (35). However, a number of technical issues may affect the signal intensity, including 
choice of coil used, artefacts from slow flowing blood, slice thickness, signal loss from myocardial 
contraction, relaxation during acquisition and TR (36). As absolute values are not quantified, 
contrast depends on the presence of “normal” myocardium. Therefore, diseases that involve 
diffuse or widespread inflammation of the myocardium cannot be identified. By providing an 
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absolute value for myocardium, T2 mapping may overcome some of these limitations (37). 
Indeed, more recently T2 mapping has been used to study the development of myocardial 
oedema in a pig model of myocardial ischemia, where not only were the T2 values in the 
ischemic myocardium higher than that of the remote myocardial, but the T2 values were found to 
parallel the measured myocardial water content (38). However, in chronic myocardial infarction, 
where there is no oedema, T2-weighted imaging is less able to differentiate healthy from infarcted 
myocardium (12). 
Pre-contrast T1 measurement may have some other novel uses. For example, methemoglobin, 
formed from thrombus, has a T1 shortening effect (39). This property can be used to detect 
intramyocardial haemorrhage in MI, (40) a marker of adverse cardiac outcomes. Shorter 
myocardial T1 following acute myocardial infarction, probably reflecting haemorrhage, can also 
detect the severity of myocardial injury and predict long-term recovery of contractile function (24). 
3.4.3  Duration of T1 Changes 
After the restoration of normal myocardial blood flow following a brief period of ischemia, the 
ECG can normalize within seconds, and functional changes normalize within 5 minutes. However 
increased intracellular water is present for a much greater period. Pathological studies 
demonstrate a gradual resolution of intracellular oedema, typically over one month (41). These 
findings were matched in an early study that showed that water content was elevated with a 
corresponding prolongation of T1 in dogs three weeks following MI (8). A T1 mapping study 
demonstrated increased T1 for up to 2 months after MI (25). Persistent small areas of 
hyperintensity have been detected with the STIR technique at up to 6 months after infarction 
(42). Potential reasons for persistent oedema could include increased wall stress, 
residual/recurring ischemia, alterations in drainage of the infarcted segments or continuing tissue 
repair. 
3.5  Post-contrast Applications 
3.5.1 T1 Mapping in Acute Myocardial Infarction 
The increased volume of distribution for gadolinium agents in infarction shortens the T1 of 
infarcted areas to a greater extent than that of normal myocardium. The larger the volume of 
distribution, the larger the concentration of gadolinium. The difference in T1 can be used to 
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distinguish between normal and infarcted tissue. This property, used in a non-quantitative 
manner in LGE imaging, is the in-vivo gold standard method of detecting MI. In acute infarction, 
the timing of the LGE sequence is critical. The injured tissue surrounding the acutely infarcted 
myocardium is swollen, and, therefore, there is increased extracellular space where gadolinium 
can accumulate. If LGE is performed early following contrast injection the hyperenhanced area 
will include both the infarcted tissue and at least some of the surrounding injured myocardium. 
Infarcted myocardium will only be brighter than the surrounding injured tissue late after contrast 
injection when the gadolinium is cleared from the viable myocardium. The best available data 
suggests an interval of at least 10 minutes is required to allow accurate infarct assessment (43) 
however, some groups wait up to 20 minutes (44). As the volume of distribution in infarcted 
tissue is much higher in infarcted than in injured myocardium, the combination of both pre- and 
post-contrast T1 mapping may better differentiate between reversible and irreversible injury. In 
addition, in acutely injured myocardium, the higher initial concentration of free water and 
therefore elevated native T1 will reduce the net change in T1 and thus reduce the effective T1-
shortening and apparent contrast enhancement (45). 
3.5.2  Chronic Myocardial Infarction 
As T1 values of chronically infarcted myocardium are lower than acutely infarcted myocardium, 
the difference in post-contrast T1 between normal and infarcted myocardium is greater in chronic 
MI. A problem with LGE imaging, irrelevant to the timing of infarct, is that it is dependent on the 
manual setting of the inversion time to null normal myocardium. infarct size may be 
underestimated of should the incorrect inversion time be chosen. 
3.5.3 Microvascular Obstruction 
Precontrast T1 values of areas of microvascular obstruction (MVO) have been found to be higher 
than that of remote myocardium, but lower than the surrounding hyperenhanced area (24). This 
may be due to reduced blood supply in this area, which limits oedema. Whereas MI detection 
using LGE reflects decreased wash-out of contrast, areas of MVO can be detected by decreased 
wash-in. The timing of the LGE imaging plays a significant role in the detection of MVO. 
Gadolinium contrast agents will diffuse passively over time, leading to eventual 
hyperenhancement. Gadolinium will, therefore, have less T1 shortening action in areas of MVO if 
T1 times are measured early after contrast administration. 
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3.6  Area at Risk 
The area at risk (AAR) refers to the hypoperfused myocardium during coronary occlusion (46). In 
revascularized myocardium, the relation between the AAR and the infarct allows the 
quantification of the volume of myocardium that reperfusion successfully salvaged from ischemic 
death. The AAR can therefore not only be used as a measure of the severity of ischemic insult, 
but it could also be used to measure the efficacy of a treatment. 
The AAR must be clearly identified to allow the study of the effects of treatments on infarct size. 
Previously, radionuclide imaging was used. This method has many limitations including use of 
nuclear tracers in an emergency department, high cost, low image resolution, and radiation. The 
unique tissue characterisation abilities of MRI make it a suitable method for identifying the area 
at risk. AAR using T2 weighted imaging has been validated against pathology (47) and AAR as 
delineated using single-photon emission computed tomography (SPECT) imaging (48).  
The basis of the identification of the AAR is similar for both T1 mapping and T2 weighted imaging, 
i.e. protons from increased water in oedematous myocardium caused by ischemia are detectable 
by increases in T1 and T2. It has been known for many years that ex-vivo T1 weighted imaging 
was able to delineate the AAR (49). These findings were recently confirmed in-vivo in a study 
demonstrating increased T1 in the AAR. In addition, this area closely matched the AAR as 
defined by microspheres (50). In keeping with the concept of oedema being a marker of severity 
of injury, T1 changes can predict myocardial salvage and myocardial recovery (24). It has been 
found that T1 is higher in myocardium that ultimately goes on to undergo infarction than in 
salvaged myocardium (28). Mapping techniques, using either T1 or T2, have the potential to 
improve the objectivity of the AAR imaging. However, a recent study examining the changes in 
myocardial water content and T2 values found that the myocardial response to injury followed a 
bimodal pattern, with an early wave dissipating in the first 24 hours, to be followed by a second 
wave peaking at day 7 (38). This study has brought into question some of the studies using T2 
weighted imaging as a marker of myocardial salvage, as the myocardial salvage index would 
vary simply with the index time since the ischemic episode.  
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3.7  Extracellular Volume 
The myocardium is made up of both myocardial cells and their surrounding interstitium. The 
extracellular volume (ECV) can increase in myocardial disease, especially through processes 
that lead to an accumulation of collagen. The increase can be diffuse or focal as in the case of 
infarction. The gold standard test, myocardial biopsy, has both significant morbidity and sampling 
error. T1 mapping provides a non-invasive alternative method of quantifying fibrosis. ECV not 
only provides a physiologically intuitive unit of measurement, increased ECV is strongly 
associated with adverse outcomes (51). 
Post-contrast T1 values alone could be used to estimate the ECV, however, there are multiple 
factors that influence post-contrast myocardial T1. By normalizing myocardial T1 in relation to 
blood T1, these factors can be ignored. The ECV is calculated using the change in T1 values in 
myocardium and blood with contrast, and the haematocrit. Increased ECV has been found not 
only in diffuse myocardial diseases such as aortic stenosis (52), hypertrophic cardiomyopathy 
(52), and non-ischemic cardiomyopathy (45), but also in ischemic heart disease(53). In acutely 
infarcted myocardium, ECV is increased as a result of cellular breakdown. In chronic infarction, 
ECV remains elevated due to the development of replacement fibrosis. ECV increases in line 
with increasing levels of myocardial damage. It has been shown that the ECV of infarcted 
myocardium is higher than the ECV in other diseases causing myocardial fibrosis (54).  
The ECV can be abnormal even in normal appearing myocardium in patients with ischemic 
cardiomyopathy (45). ECV increases with worsening left ventricular function. This finding 
correlates with pathological findings from explanted hearts of patients with ischemic 
cardiomyopathy (55), in which interstitial fibrosis in areas remote from infarction was increased 
over 2-fold in comparison to controls. Raised ECV has now been found to be a marker of short-
term adverse outcomes in a broad range of patients (51), and, in fact, is a stronger marker of risk 
than left ventricular ejection fraction. 
It can be shown that the ECV of salvaged myocardium is higher than that of the remote 
myocardium as a result of extracellular oedema. ECV can delineate the AAR from infarcted and 
normal myocardium (56). The post-contrast T1 in the AAR has a value less than 2SD from the 
remote myocardium (50 ms approximately), and is, therefore, difficult to detect using LGE alone. 
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The combination of pre- and post-contrast images demonstrates that the ECV in the AAR is 
significantly elevated from that of remote myocardium. 
  
3.8 Technical Aspects 
T1 mapping uses multiple scans with varying degrees of signal recovery to calculate T1 values on 
a pixel-by-pixel basis, from which a parametric image can be reconstructed. Pixel intensities in 
these images correspond to T1 values. These can then be presented as a grey-scale or colour 
map of the myocardium. 
To produce raw data with varying degree of signal recovery, most T1 mapping pulse sequences 
acquire images at different delay time following a 180° or 90° prepulse (inversion recovery or 
saturation recovery, respectively). Inversion pulses can only be used when the signal has 
recovered from all preceding experiments. In order to omit long waiting times, clinical inversion 
recovery-based techniques (e.g. modified Look-Locker inversion recovery, MOLLI (4)) are based 
on the method that was introduced by Look and Locker (57) and acquire data at multiple time 
points following a single inversion pulse. Inversion pulses provide higher dynamic range than 
saturation pulses, but the necessity to use multiple-readout schemes introduces a certain degree 
of heart rate dependence. This becomes relevant at high flip angles (>35° in balanced steady-
state free precession) and high heart rates (>100 beats per minute) (23). Saturation pulses 
provide a lower dynamic range to start with but, when carried out separately for each raw image, 
allow for using high flip angles (e.g. 70°) without heart rate dependence (58). As a result, both 





Figure 3-2. 4 chamber MR Imaging in a patient with recent antero-septal myocardial infarction. Upper Row - 
Cine MR imaging in diastole (a) and systole (b) demonstrating apical hypokinesia. Lower Row – (c) T1 
Mapping showing increased T1 in the apico-septal region. (d) ECV mapping demonstrating varying degrees 
of transmural myocardial injury. (e) LGE imaging demonstrating apico-septal myocardial infarction. 
 
3.8.1 Additional Factors Affecting T1 
Factors that influence T1 itself include cardiac phase and field strength. The measured T1 value 
will reflect the T1 of blood flowing through the myocardium in addition to that of the myocardium. 
As myocardial blood flow occurs primarily during diastole, the phase in which the T1 is measured, 
systole or diastole, affects T1 measurement. Precontrast, arterial blood T1 is higher than that of 
myocardium, resulting in higher T1 in diastole than systole (59, 60).   
Minor differences (2% approximately) have been noted in the measurement of T1 both pre- and 
post-contrast between the septal and non-septal regions (59), this may be a result of a 
combination of factors, including magnetic susceptibility artefacts, receiver coil sensitivity, and 
signal gradient between septal and non-septal myocardium due to greater distance from the 
receiver coil elements. No difference, however, has been found between basal, mid and apical 
regions (61).  
Gender and age appear to play a role in the range of normal T1 values (62). Women have a 
higher ECV and native T1 when compared with men. In men, there is a gradual increase in native 
T1 value and ECV with age, whereas women appear to have fewer changes in ECV and T1 with 
a b 
c d e 
77 
 
age. Some of the differences in T1 values between the genders may be related to haematocrit – 
the haematocrit will influence the value of the blood, with a lesser impact on the myocardial T1 
value. Women tend to have a lower haematocrit than men, leading to a higher T1 values in blood, 
with a contribution to higher myocardial T1 values. Normalisation for haematocrit has been found 
to eliminate differences between the genders (60). The changes in myocardial T1 values with age 
would appear to be explained by the increased fibrosis found as part of normal aging. 
Thinner walled myocardium is more challenging to assess accurately. A region of interest in 
thinner structures, may include a higher amount of voxels which include a contribution from the 
surrounding blood pool. As the T1 in blood and myocardium are significantly different, this partial 
volume effect could result in artificially high native T1, and artificially low post-contrast T1 values. 
Therefore, thin walled myocardial infarctions and the relatively thin walls of the right ventricle are 
technically challenging to assess. However, with improvements in spatial resolution, T1 mapping 
can be expected to overcome some of these challenges. 
  
3.9 Potential of T1 Mapping in Ischemic Heart Disease 
Native and post contrast T1 mapping provides previously unavailable insights into myocardial 
diseases, and, in particular, myocardial oedema and fibrosis. The recent consensus statement 
acts as a guide towards the standardisation of imaging techniques and reporting which will help 
increase the clinical use of these measurements (63).  
T1 mapping provides a quantitative method to complement both oedema imaging (STIR) and 
infarct imaging (LGE). An advantage of T1 mapping is that by using a quantitative technique, both 
intra- and interobserver agreement are very high (59, 61). The data provided by pre and post 
contrast T1 mapping could help in the diagnosis of patients with acute chest pain, distinguishing 
acute coronary syndromes from myocarditis and Takotsubo cardiomyopathy (64), and acute from 
chronic infarction.  
In chronic ischemic heart disease, standardised T1 thresholds or ECV values could detect and 
automatically quantify MI. In addition, the complexities of the area at risk could be analysed, 
looking for MVO and myocardial haemorrhage and assessing the peri-infarct zone. This could be 
of clinical importance, as some studies have found that MVO is a predictor of adverse outcomes. 
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The peri-infarct zone is a potentially important pathophysiological substrate for arrhythmias. 
Presumptively normal myocardium has been used in prior studies to differentiate the infarct core 
(eg, more than three standard deviations) from the heterogeneous peri-infarct zone, containing 
viable myocardium (eg, between two and three standard deviations). T1 mapping could identify 
this border zone that may provide a substrate for ventricular tachycardia and sudden cardiac 
death (26).  
T1 mapping can help distinguish ischemic LGE from non-ischemic LGE (45). In addition, it can 
assess the “normal” appearing myocardium for fibrosis, as increases in ECV are closely linked to 
increased chances of adverse cardiac events (51).  
T1 mapping could be used to predict myocardial recovery of function after revascularization, 
where it offers a potential alternative to the conventional method that uses the percentage of 
transmurality. In the field of research, it offers a quantitative alternative to T2 weighted methods 
to measure the area at risk from MI in NSTEMI and STEMI. Coronary microembolization is a 
frequent complication during percutaneous coronary intervention (PCI). As LGE using 
semiautomated thresholding underestimates myocardial damage (65), T1 mapping techniques 
could identify areas of reversible and irreversible injury with the aim of improving 
revascularization techniques. 
Diffuse myocardial fibrosis is a common histological feature of the failing heart. Endomyocardial 
biopsy (EMB) is the standard of reference for quantifying fibrosis but is an invasive procedure 
and prone to sampling error. It is known that the development of diffuse fibrosis is influenced by 
neurohormonal factors including angiotensin-converting enzyme, angiotensin II, catecholamines, 
and aldosterone. Pharmacological therapy with beta-blockers and angiotensin-converting 
enzyme inhibitors can reduce diffuse myocardial fibrosis (45). ECV has a low variability across 
scans, and could be a viable tool for evaluating clinical trial outcomes (66). This property may 
make it possible to non-invasively, serially, and quantitatively assess fibrosis in the non-infarcted 
myocardium as a potential endpoint for pharmacological intervention in heart failure, using small 
groups of patients, significantly reducing trial costs. Looking to the future, the use of CMR tissue 






T1 quantification has a long history in the study of ischemic heart disease. Recent imaging 
sequence developments allow T1 values to be quickly and reproducibly quantified on a pixelwise 
basis and presented as T1 maps using clinical MR systems. Oedema from acute myocardial 
ischemia and replacement fibrosis in chronic MI can be accurately detected and quantified. The 
combination of pre- and post-contrast images can not only identify and differentiate acute and 
chronic injury but also demonstrate a range of myocardial injury by measuring ECV. 
The precise role of T1 mapping in the evaluation of ischemic heart disease remains to be defined, 
however, its broad potential, and the fact it is a quantitative measurement show much promise 
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Chapter 4 -  Closed Chest Model of Ischemia reperfusion 
4.1 Abstract 
Current models for real-time study of the effects of myocardial ischemia/reperfusion (I/R) have 
major limitations and confounders, including the surgical stresses of a thoracotomy and the 
abnormal physiology of an open chest. The need to reposition the animal after induction and 
termination of ischemia in conventional models interferes with the study of the early changes 
associated with ischemia, rendering a direct comparison of pre-ischemia and post-ischemia 
images difficult. We developed a novel “closed chest” model of I/R to overcome these issues (1). 
Following thoracotomy, we sutured a balloon occluder to the left coronary artery (LCA). We used 
both visual inspection and ECG to assess for successful occlusion and reperfusion of the 
coronary artery at the time of operation by brief inflation and deflation of the balloon. The tubing 
was then placed under the skin, and the incision closed. Following a recovery period (5-10 days), 
the animals underwent MRI. We performed a baseline assessment of left ventricular (LV) 
function, then inflated the balloon was inflated and repeated LV measurement using cine MRI.  
The occluder was successfully placed in 40 of 44 animals. 4 developed intraoperative 
complications; 2 large myocardial infarction, 2 terminal bleeding. 6 died in the week following 
surgery, (4 sudden deaths (presumed arrhythmic), 1 anterior infarction, 1 sepsis). Cine-MRI 
demonstrated localised hypokinesia in 31 of the remaining 34 animals. LV ejection fraction (EF) 
was reduced from 63% ± 7% at baseline to 49% ± 9% during coronary occlusion. LV EF 
removed to 61% ± 2%. The area at risk as measured by staining of the heart was 41.9% ± 16%. 
This method allows the effects of ischemia/reperfusion to be studied before, during, and after 
coronary occlusion. Ischemia can be caused while the animal is in the MRI. This new and 
clinically relevant small animal model is a valuable tool to study the effects of single or repeated 






Experimental myocardial occlusion has been used as a model to study the effects of coronary 
ischemia (2, 3) and ischemia/reperfusion (3) for many years. Initial studies involved the use of 
larger mammals (dogs, pigs, etc.) but issues of cost and ethics led to the increasing use of small 
animals such as mice and rats as models for cardiovascular disease. 
Models of myocardial ischemia in small animals have typically used one of a number of open-
chest techniques. The basic permanent occlusion model is one where the left coronary artery 
(LCA) is sutured closed (4). The simplest open chest myocardial ischemia/reperfusion (I/R) 
models involve a suture fastened around the LCA for a period before being released (5). In an 
alternative model, a suture is passed around the LCA, and then both ends are passed through a 
piece of plastic tubing. Tightening the suture and securing it causes ischemia, releasing the 
suture allows reperfusion. Closed chest models have been developed involving the use of snares 
(6, 7) or a system of sutures around the LCA (8). 
However, all of these models have important limiting factors. While the animal is in the coil, 
access is limited. The need to induce ischemia, then place the animal in the coil means the study 
of the initial, or of brief periods of ischemia, is not possible. Ideally, animals would be studied at 
baseline, during, and following I/R. The need to reposition and repeat the localiser scans 
following each manipulation can interfere with this. 
All open-chest models involve a high mortality in the first 24 hours, for example, 40-50% in the 
paper from Pfeffer et al. (4). This mortality not only plays an important role in the planning of 
experiments but also is a significant factor in animal welfare and ethical approval of studies.  
Our study goal was to develop a closed-chest model of I/R in the rat allowing for repetitive 
opening and occlusion of a coronary artery in both laboratory and CMR environments. 
 
4.3 Methods 
All procedures were approved by local animal care authorities. Male Sprague Dawley rats (n=44, 
weight 367 ± 67 g) underwent thoracotomy for surgical preparation of the coronary arteries. After 
a recovery period of 5 to 7 days, animals were taken to an MRI system and subjected to 
coronary occlusion (15 - 90 minutes) and subsequent reperfusion while in the MRI.  
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The occluder (VO-1.5F, DocXS Biomedical Products, Ukiah, CA, USA) consists of a length of 
silicone rubber tubing of 1.5 mm diameter with an inflatable balloon of 3.5mm width with an 
eyelet at one end (Figure 4-1). The balloon can be secured in place with suture material via the 
eyelet. The balloon is inflated by injecting air or liquid into the balloon and deflated by simply 
withdrawing the air or liquid. A 20G cannula or blunted needle may be used to access the tubing. 
A cannula can be attached to extension tubing of various lengths to allow inflation and deflation 
of the balloon from a distance. 
 





Rats were anaesthetized with an initial dose of 4% isoflurane in an air/oxygen (4:1) mixture using 
an induction chamber, intubated, and ventilated at a rate of 70 breaths per minute (7025 Rodent 
Ventilator, Ugo Basile, Comerio VA – Italy). Anesthesia was maintained using 1.5-2% Isoflurane 
in an air/oxygen (4:1) mixture during the surgery. Body temperature was recorded and 
maintained at 37.5° using a flexible rectal temperature-sensing probe with Homeothermic 
Blanket Control Unit (Harvard Apparatus). ECG electrodes were attached to the paws, and a 
baseline ECG was obtained (PowerLab, AD Instruments, Colorado Springs, CO, USA). Heart 
rate and ECG were continuously monitored during the surgery (PowerLab, AD Instruments, 
Colorado Springs, CO, USA).  
We performed an incision in the left mid-clavicular line then with blunt dissection separated the 
pectoralis muscles to expose the ribcage. A Barraquer eye speculum was used to keep the chest 
muscles widely separated. Thoracotomy was performed via fourth intercostal space. A rib 
spreader was used to obtain a clear view of the heart. The pericardium was gently torn open, 
avoiding damage to the heart or blood vessels. 
In the rat, the LCA consists of a single vessel with few branches. There is no true circumflex, and 
collaterals are rare. This allows the creation of large, quite uniform areas of ischemia/infarction. A 
6-0 Ethicon prolene blue monofilament polypropylene suture was passed under the LCA, from 
below the left atrial appendage to below the pulmonary outflow tract. The suture was then 
passed through the eyelet of the occluder. Finally, the occluder was loosely secured around the 
mid-portion of the LCA (Figure 4-1). Briefly inflating and deflating the balloon tested for reversible 
occlusion. Both the ECG, with ST segment elevation and resolution, and reversible myocardial 
blanching and hypokinesis, were used to confirm ischemia. The non-balloon end of the occluder 
was then passed from the chest cavity, via the second intercostal space, and looped in a pouch 
created under the skin of the animal. After instrumentation, the chest was closed following the 
evacuation of the air inside the chest. After surgery, the animals were placed in a recovery cage 
for 2 hours, then transferred to the animal care facility for further recovery. Animals received 0.03 
mg/kg of buprenorphine subcutaneously pre-operatively, followed by a further dose ever 8-12 
hours if required. Rats were also given Acetaminophen 5mg/ml in their drinking water for 72 




After induction of inhalative anaesthesia (isoflurane-oxygen, 2.5%) and weighing, the feet were 
cleaned before attaching MRI-compatible electrocardiogram (ECG) electrodes. A small incision 
was performed to locate the occluder tubing. The distal end was then attached to a 20G plastic 
cannula and 3-way stopcock. Extension tubing was attached to allow the balloon to be inflated 
and deflated from a distance of 1 metre. The animals were then placed on and fixed to a 
dedicated animal bed, and the bed then positioned within the MRI coil. A warm water heating mat 
was placed over the rat. The temperature was monitored using a fibre-optic rectal probe (Luxtron 
FOT Lab Kit, LumaSense Technologies, Inc., Santa Clara, USA) and maintained at 37C ± 1°C. 
Throughout the examination, anaesthesia was maintained via inhalation of isoflurane-oxygen 
(0.8– 1.5%). After the initial MRI images were acquired, the artery was occluded for 15 minutes. 
Occlusion was confirmed with ECG Tracing and by hypokinesis of the LV wall on cine MR 
imaging. 
Following the specified duration of ischemia, the occluder was opened. Animals were then 
maintained in the scanner for a minimum of 90 minutes, before being removed.  The animals 
were subsequently euthanized and the hearts removed for staining. 
A 3-T clinical MRI system (Achieva; Philips Healthcare, Best, The Netherlands) equipped with a 
dedicated solenoid coil for rats was used for all studies. After generation of survey images and of 
a long-axis set of cine images, a stack of left ventricular (LV) short-axis cine images was 
acquired (phases, 30; repetition time, 6.8 ms; echo time, 3.3 ms; flip angle, 15°; field of view, 80 
x 64 mm; acquired voxel size, 0.4 x 0.4 x 1.5 mm; number of signal averages, 2; slices, 7; 
interslice gap adjusted to allow for coverage of the entire LV range, -0.3 to 0.0 mm, where a 
negative gap refers to a slice overlap). Short axis cine images were repeated after inflation of the 
occluder to assess LV function. 
Histology was performed to confirm the presence of infarction and assess the area-at-risk in all 
animals similarly to methods previously described (9). Animals were euthanized by 
exsanguination following an overdose of isoflurane anesthetic. Briefly, the heart with occluder 
attached was swiftly removed. Re-inflating the occluder balloon re-occluded the LCA. Evan’s 
blue dye (2%, 1 ml) was injected retrogradely into the ascending aorta to delineate the area at 
risk (Figure 4-2). The heart was cut parallel to the atrio-ventricular groove at the centre of the risk 
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area. It was then cut into 1-mm thick slices that were incubated in 1% triphenyltetrazolium 
chloride (TTC) at 37°C for 20 min. Viable myocardium stains red while necrotic myocardium 
remains unstained by TTC. The slices were photographed using a colour camera (Canon 
Powershot G12). The images were stored on a computer and analysed using ImageJ (Rasband, 
W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2011). The area stained by a blue dye is identified as perfused 
area and the unstained area as the area at risk (AAR). The infarcted area is identified as the 
unstained white area by TTC. AAR was normalized by the whole LV area as AAR/LV. 
 
Figure 4-2. (a) Occluder in position on the left ventricle (LV), sutured in position below the left atrium (LA). 
(b) Reinflating the occluder occludes the left coronary artery. Blue dye is then perfused into the aorta but 




40 of 44 animals operated had the coronary occluder successfully placed. Typical intraoperative 
ECG findings can be seen in Figure 4-3, showing ST elevation and normalization on inflation and 
deflation of the occluder. Immediate mortality of the surgical procedure was low at 9% (2 animals 
developed a large infarction following occluder placement and were euthanized. 2 animals 
developed terminal bleeding following passage of the needle through the myocardium). Most 
animals resumed normal behaviour shortly after the surgery. 
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In the week following the surgery, 6 of the remaining animals died, (4 sudden deaths (presumed 
arrhythmic), 1 large anterior infarction, 1 abdominal sepsis from intraoperative injury). 
 
 
Figure 4-3. Sample ECG of the Rat showing (a) normal ECG prior to occluder inflation, (b) ST elevation on 
occluder inflation, and (c) ST resolution following occluder deflation 
 
4.4.2 MRI 
We had successful I/R in 31 of the remaining 34 animals. I/R was confirmed by cine MRI, which 
demonstrated localised myocardial hypokinesia (Figure 4-4). Typical ECG changes of ST 
segment change, followed by loss of R wave height were seen in 29 of the 33 animals. 
Arrhythmia (ventricular ectopy or ventricular fibrillation) developed in most animals (29 of the 31 
with confirmed ischemia). One animal developed terminal ventricular fibrillation following 15 
minutes of myocardial ischemia; however, all other animals spontaneously reverted to sinus 




Figure 4-4. SSFP Short Axis still images through the left ventricle (LV) before occluder inflation in diastole 
(a). Normal LV systolic function can be seen in the systolic image (b). A large area of anterolateral 
hypokinesia (arrows) can be seen during occluder inflation (c). Inversion recovery images early following 
gadolinium injection (d) demonstrate the hyperenhanced anterolateral area at risk (arrows). 
 
Baseline LV ejection fraction (EF) was measured at 63% ± 7%. During coronary occlusion, EF 
decreased to 49% ± 9% during coronary occlusion. Following reopening of the artery, LV EF 
removed to 61% ± 2% one hour following reperfusion. 
In the 3 animals without changes in the ECG or LV function, the occluder was not surrounding 
the LCA (2 animals) or the suture fastening the occluder to the myocardium had become loose (1 
animal). 
After removing the heart, we were able to re-occlude the coronary artery by reinflating the 
occluder in all animals with confirmed ischemia. The AAR was 41.9% ± 16%. Typical staining of 
the heart can be seen in Figure 4-5. The AAR of infarction remains red while the rest of the heart, 
supplied by the right coronary artery is stained dark blue. In addition, one animal also had a small 





Figure 4-5. Staining of the heart showing the large area at risk of myocardial infarction (stained red) 
supplied by the left coronary artery. The myocardium stained blue is supplied by the right coronary artery. 
 
4.5 Discussion 
In this study, we present a novel small animal model that allows for studying the effects of I/R 
with or without preceding or subsequent episodes of brief occlusion (conditioning) in space-
constrained environments such as MRI.  
The availability of realistic small animal models is important for cardiovascular research, as 
preclinical studies help to generate and test hypotheses for new therapeutic strategies and 
provide the link between basic and clinical research. The presented model allows the 
investigation of the course and mechanisms of I/R without confounding influences from major 
surgery. Furthermore, the effects of ischemic preconditioning and postconditioning can be 
studied as opening and occlusion of the coronary artery can be performed repetitively. 
The extent of myocardial damage that is caused by myocardial ischemia is not only determined 
by the duration of coronary occlusion, but also by the metabolic pathways that are activated 
immediately before, during, and after ischemia. In the open-chest model, a number of factors can 
cause systemic stresses that influence these pathways. Surgical blood loss may cause 
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hypovolemia leading to increased sympathetic activity and ultimately to acidosis, endothelial 
dysfunction, and redox state, as well as stimulation of inflammatory and anti-inflammatory 
cascades. Surgery itself causes an inflammatory response. Lifting and moving the heart to 
access the LCA can directly damage the heart, or result in twisting or kinking of the aorta, which 
reduces coronary blood flow and act as an unwanted preconditioning episode. Ventricular 
geometry may change with the removal of the pericardium in an open chest. Finally, the open 
chest exposes the core of the body, increasing the risk of hypothermia. Mechanical ventilation 
can further exacerbate this problem. Hypothermia can critically influence the experimental 
outcome. For example, a fall in temperature by only 1°C reduces infarct size by 10% (10). 
The use of a closed-chest model allows for separating surgery-related systemic effects from the 
specific effects of I/R experiments. In a previous experiment, Michael et al. (6) found that, in 
sham-operated animals, the acute surgical trauma associated with open-chest preparations 
resulted in significant and highly variable background levels of inflammation. These systemic 
effects could interfere with the measurement of inflammation due to I/R. Other studies have 
looked at the effects of the open-chest model on the recovery of systolic thickening after 
ischemia and found that the open chest model greatly exaggerated the effects of myocardial 
stunning (11). The time required to minimise the confounding effects of surgery is unknown. 
Inflammatory processes including leukocyte recruitment play a major role in the extension of 
myocardial damage after ischemia and reperfusion (12). Sham-operated animals have been 
found to have significant levels of inflammation, which can be indistinguishable from that of 
animals that undergo I/R (13). It has been shown that inflammatory markers (TNF-α and IL-6 
mRNA) in sham-operated mice return to normal within three days of operation (14). In our 
experiments, we waited at least five days from time of operation to allow the effects of the 
operation to be minimised. 
In our series, the model was associated with a mortality rate of 23%, with only one animal dying 
during the I/R experiments. For open-chest models, examples of mortality rates range from 35% 
(15) to 65% (16). A reduction in overall mortality could be expected, as the I/R experiments are 
performed when the animals have recovered from the impact of the thoracotomy and thus are in 
a much more stable condition. The AAR in our experiments was broadly similar to other 
techniques of myocardial ischemia and infarction, such as 4-59% in the paper from Pfeffer et al. 
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(4). Technically, the operation is very similar to the traditional suturing of a coronary artery, and, 
therefore, those skilled in the basic procedure should be able to perform this operation without 
significant difficulty. 
Between the thoracotomy and I/R experiments, the tubing of the occluder was placed 
subcutaneously. Exposed tubing would act as an infection source, and animals could not be 
housed in groups in cages, which is a less stressful arrangement than isolated housing. 
The ability to occlude the artery without disturbing the position of the animal is crucial for imaging 
experiments. If the animal remains in the same position, the pre- and post-occlusion images can 
be compared without a need for repeated scanning or the need for image correction. 
MRI has been shown to detect myocardial oedema and wall motion abnormalities in clinical 
patients. With the proposed model, MRI can be used for comprehensive non-invasive 
characterization of the course of myocardial injury during experimental I/R.  
 
4.6 Conclusion 
In summary, the presented model overcomes several limitations of previous models and enables 
in-vivo research in the effects of various schemes of I/R on the myocardium in rats. It provides 
the possibility of causing myocardial ischemia of varying durations, with the advantage of not 
having to reposition the animal. This is crucial to study the rapid metabolic and structural 
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Chapter 5 -  Validation of SALLI Imaging 
5.1 Abstract 
Small-Animal Look-Locker Inversion Recovery (SALLI) is a multi-modal imaging method that 
simultaneously generates cardiac T1 maps, cine MRI and inversion recovery (IR)-prepared 
images for high heart rates. T1 mapping by SALLI has been validated against histology in an 
animal model of hypertensive heart disease (1), however the assessment of left ventricular (LV) 
function by SALLI-Cine MR and infarct size by SALLI-LGE have not yet been validated. Our aim 
was to compare the measurement of LV function between the SALLI-Cine sequence and the 
standard Cine MRI sequence, and infarct size between late gadolinium enhancement (LGE) 
using SALLI-LGE and histology. 
Six healthy rats and 18 rats with surgically induced myocardial infarction were imaged. MRI was 
performed on a whole-body 3.0T MR unit with a 70 mm solenoid coil for rats. A stack of LV short-
axis cine images was acquired from apex to base. Short axis SALLI MR imaging was performed 
in the same seven short axis orientations, before and after gadolinium contrast injection. 
Following imaging, the hearts were harvested, stained with triphenyltetrazolium chloride (TTC) 
and infarct size was measured. Image quality was visually assessed and compared between 
imaging modalities and between pre- and post-contrast SALLI images. Ejection fraction was 
compared between standard cine and SALLI-Cine imaging. Infarct size by SALLI-LGE was 
compared with infarct size by TTC staining. 
Image quality was good or adequate in all cases. LV function and infarct size were similar with 
SALLI-Cine vs. Cine (EF 59.8 ± 12% vs. 60.8 ± 12%, p=0.42) and SALLI-LGE vs. histology 
(infarct size 21.9 ± 18% vs. 23.5 ± 18%, p=0.28), respectively. SALLI-LGE generated good 
contrast between infarcted and normal myocardium, however, contrast between blood and 
infarcted myocardium was less marked. Image quality was similar between the pre- and post-
contrast SALLI-Cine images, with comparable measured ejection fraction. 
SALLI multimodal imaging provides an alternative to conventional cine MR and IR sequences. 
SALLI measurements of ejection fraction and infarct size are comparable to standard MR Cine 
imaging and histology across a range of ventricular function and infarct sizes. Image quality is 
comparable between both MRI methods. SALLI offers an efficient alternative method to 
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conventional Cine MR and LGE MR imaging methods. As SALLI generates multimodal images 
from the same dataset, this approach could not only be time saving but has the advantage of 






Cardiac Magnetic Resonance Imaging (CMR) is the clinical reference standard for assessment of 
ventricular function and detection of myocardial infarction (2). When compared to standard 
clinical MRI, small animal MRI presents additional challenges, including the high heart rates (200 
to 600 beats per minute) and small size of the animals. To maximise the signal-to-noise ratio, 
most small animal imaging is carried out on dedicated high field systems with field strengths 
ranging from 4.7 to 11 Tesla (T) (3). However, these dedicated scanners are not as widely 
available as standard clinical scanners, which operate at lower field strengths of 1.5 to 3 T. In 
addition, dedicated pulse sequences are required to allow cardiac imaging. The ability to perform 
imaging on clinical scanners in a time efficient manner could allow the development of new 
research opportunities. 
However, there are a number of challenges in adapting these scanners for small animal CMR. 
Reliable ECG signal is required to perform triggered imaging. Options to allow this include the 
use of neonatal electrodes attached to the clinical ECG system, or a dedicated small animal ECG 
monitor. The software on the scanner should be adjusted to allow for the high heart rates of the 
small animals. As breath holding is not possible, signal averaging or respiratory gating is required 
to minimize the artefact from respiratory motion.  
Anaesthesia is required for the examination. Inhaled anaesthetics, such as isoflurane, are the 
most practical method, however, specialised small animal gas delivery and extraction systems 
are then required. These anaesthetics have been found to have minimal effects on cardiac 
function (4). As animal temperature rapidly falls during anaesthesia, temperature needs to be 
monitored and controlled by the use of heating pads or warm water systems.  
The spatial resolution required in small animal imaging is 5-10 times that of standard clinical 
imaging, with a resulting loss in SNR. This places increased demands on the hardware, requiring 
high field strengths with strong and fast switching gradients. These need to be combined with 
dedicated small animal radiofrequency receiver coils, although other small volume coils such as 
wrist coils can be used.  
In small animals, the most frequently used method to study cardiac structure and function is a T1-
weighted cine gradient-echo (GRE) technique (Figure 5-1). This pulse sequence acquires data 
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from multiple heart phases for a single imaging slice. As the heart is moving so rapidly, 
segmented k-space acquisitions must be used. This allows myocardial mass, LV size, mass, 
shape, wall thickness, epicardial and endocardial contours and ejection fraction (EF) to be 
measured (5). 
 
Figure 5-1. A typical ECG-gated gradient-echo (GRE) cine MRI acquisition. For the GRE sequence 
diagram (bottom), the RF (radiofrequency) excitation pulse (α) and echo can be seen. Each slice is 
acquired using slice-select (SS), phase encode (PE), and readout (RO) gradients. The echo time (TE) is the 
time between the RF excitation pulse and the MR signal. The repetition time (TR) is the time between 
excitation RF pulses and determines the temporal resolution. Individual images are acquired at different 
phases (e.g., 1, 2, 3…) of the cardiac cycle. The maximum number of cardiac phases that can be acquired 
is determined by the TR and the interval between consecutive heartbeats. The phase encoding gradient 
changes over multiple heartbeats to acquire a complete image. From (3), used with permission. 
 
The standard MRI technique to assess myocardial infarct size is late gadolinium enhancement 
(LGE) imaging (6), which is based on an IR-prepared pulse sequence (Figure 5-2).. The 
diagnostic quality of this method depends on the selection of an appropriate inversion time. While 
this is easy to achieve at human heart rates where inversion and readout pulses can be 
performed within the same cardiac cycle, inversion timing becomes challenging at heart rates of 
>200 bpm where several cardiac cycles have to be included. Some studies in small animals have 
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reported adaptations of clinical IR based sequences (7, 8), or conventional T1 weighted 





Figure 5-2. An inversion recovery (IR) spoiled gradient-echo sequence for late gadolinium enhancement 
(LGE) imaging. A non-selective inversion pulse (black box) is applied at an inversion time (TI) prior to the 
image acquisition (grey box) in mid-diastole. A long TR 2–3 times the T1 of normal myocardium is chosen to 
allow sufficient recovery of the inverted magnetisation. The trigger delay Td is chosen to allow imaging in 
diastole, the time of cardiac motion. Because a non-selective inversion pulse is used, multi-slice image 
acquisition can be used to maximize imaging efficiency and allow improved coverage of the heart. From (3), 
used with permission. 
 
 
Performing T1 mapping in small animals is challenging as the high heart rates prevent the use of 
single-shot acquisitions and require segmented imaging to allow for the shorter cardiac cycles. 
As previously mentioned, much small animal imaging is performed at high field strength, which 
results in increased T1 times. This, in turn, prolongs scan times due to the need for near-total 
signal recovery in IR-based methods.  
In general, CMR of large animals is similar to humans, as the dimensions and heart rate are 
comparable. However, for reasons including cost, ethics and the availability of genetically 
modified animals, small animal research plays an important role in the study of cardiovascular 
disease. Whereas the anatomy of rats and mice is similar to that of humans, the rapid 
movements of the heart require high temporal resolution. Blood flow artifacts provide additional 
challenges to successful imaging. The small dimensions are yet another challenge, with an 
average size of a rat heat being about 20mm from apex to atria with a wall thickness of 2-3mm. 
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Small Animal Look-Locker Inversion Recovery (SALLI) is a multi-modal imaging technique that 
simultaneously generates cardiac T1 maps and cine and IR-prepared images at high heart rates 
(11). The pulse sequence diagrams can be seen in Chapter 2 (Figure 2-13, Figure 2-14). This 
method allows for time-efficient assessment of T1 properties, function, and late gadolinium 
enhancement from a single set of image data. SALLI generates multiple IR based LGE images 
with a variety of predefined steps of inversion time (TI) (e.g. 25 ms) from the image data 
available within the interval. This avoids the necessity of performing a pre-scan to obtain 
information on optimal nulling of healthy myocardium. In addition, images of corresponding heart 
phases from all three modalities always spatially match each other. A direct comparison of 
findings is then possible without the need for further image registration. T1 mapping using SALLI 
has been validated (1), however the other two datasets of cine images and IR images, used to 
assess myocardial function and myocardial infarction following gadolinium contrast 
administration respectively, remain to be validated. In this study, we aimed to compare SALLI-
cine MR versus conventional cine MR and SALLI-LGE against histology for assessment of LV 





All procedures and experimental protocols were approved by local authorities and performed in 
accordance with both the Federation of European Laboratory Animal Science Associations 
(FELASA) guidelines and recommendations and German federal law regarding the protection of 
animals. 
5.3.1 Infarct Procedure 
Male Sprague-Dawley rats (n=24; age, 16-22 weeks; weight, 170-340g), (Charles River, 
Sulzfeld, Germany) were studied. To allow the study of a range of LV function, the rats were 
divided into 2 groups, a group with myocardial ischemia/infarction of various duration (18) and a 
smaller control group (6). 
The infarct operation was carried out as described in Chapter 3. Briefly, following anesthetization, 
intubation and ventilation, a thoracotomy was performed via fourth intercostal space. A coronary 
occluder was sutured in position by passing a 5-0 Ethicon prolene blue monofilament 
polypropylene suture around the left coronary artery (LCA). Correct positioning was confirmed by 
ST segment elevation and resolution on ECG, and by myocardial blanching and hypokinesia on 
inflation and deflation. After surgery, the animals were placed in a recovery cage for 2 hours, 
then returned to the animal care facility.  
After a 1-week recovery period, the animals were re-anesthetized, and the coronary occluder 
was inflated to occlude the LCA. The duration of ischemia was 15 (6 rats), 30 (6 rats), or 60 
minutes (6 rats) to provide a range of infarct sizes and left ventricular function. The control group 
received the same operation but did not undergo coronary occlusion.  
The animals were allowed to recover, and MRI was performed 1 week after myocardial ischemia. 
On completion of the final MRI study, animals were euthanized and their hearts were excised. 
The control group comprised of rats who did not undergo myocardial ischemia who were imaged 
once. 
5.3.2 MRI Protocol 
Experiments were carried out with a whole-body 3.0-T MR unit (Intera and Achieva; Philips 
Healthcare, Best, the Netherlands) equipped with a dedicated coil for rats. After generation of 
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survey images and of a long-axis set of cine images, a stack of left ventricular (LV) short-axis 
cine images was acquired (phases, 30; repetition time (TR), 6.8 ms; echo time (TE), 4.60 ms; flip 
angle, 15°; field of view, 80×64 mm; acquired voxel size, 0.4×0.4×1.5 mm; number of signal 
averages, 4; slices, 7; slice thickness 1.5 mm).  
Short axis SALLI MR imaging was performed in the identical 7 short axis slices from apex to 
base both before and after an injection of 0.3 mmol/kg of gadolinium contrast medium 
(gadobutrol [Gadovist]; Bayer-Schering AG, Berlin, Germany). Typical SALLI parameters were: 
acquisition duration, 4000 ms; relaxation duration, 4000 ms; phases, 4; flip angle, 10°; field of 
view, 56×56 mm; acquired voxel size, 0.6×0.6×2.4 mm; TR, 7.6 ms; TE, 3.1 ms; number of 
signal averages, 4; total acquisition time, 5 minutes 40 seconds. 
5.3.3 Image Analysis 
Images were reconstructed using a customized reconstruction framework (ReconFrame; 
Gyrotools, Zurich, Switzerland) implemented with Matlab software (MathWorks, Natick, USA). 
Images were transferred to a CMR analysis software package (CMR42 version 4.0; Circle 
Cardiovascular Imaging Inc, Calgary, Alberta, Canada) and analyzed. For each of the sets of 
data, the image quality was visually assessed (good, no artifacts = 1, minor artifacts = 2, non-
evaluable, major artifacts = 3). Endocardial contours were manually traced in systole and 
diastole to allow calculation of LV ejection fraction from both cine MR and SALLI datasets. To 
evaluate if the presence of contrast agents altered image quality or LV function measurement, a 
subset of 10 animals had left ventricular function measured in both pre- and post-contrast SALLI 
images. 
Infarct size was calculated from the SALLI-LGE dataset. Firstly, the optimum TI was manually 
selected. On the selected images, subepicardial and subendocardial contours of the LV 
myocardium were manually traced. The infarct volume was then manually traced. Total infarcted 
area was expressed as percentage of the LV volume, given by the sum of the volume of high 
signal intensity on LGE (necrosis/scar) for all slices divided by the sum of the LV myocardial 
cross-sectional volumes (%LV). 
We chose to quote contrast resolution to give a comparative estimate of contrast between the 
blood, infarcted and remote myocardium, as there are a number of challenges with calculating 
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SNR (12). Contrast resolution is defined as CR = (SA-SB)/(SA+SB). The image with optimal TI 
was defined visually as the value at which the signal intensity (SI) of the viable myocardium was 
nulled. Signal intensities in the LV blood pool, healthy and infarcted myocardium were measured 
in 3 consecutive slices containing both infarcted and healthy myocardium using Osirix (Pixmeo 
SARL, Bernex Switzerland). For each slice, an elliptical region of interest (ROI) was selected to 
include the largest continuous area of enhanced myocardium possible; a second ROI of the 
same size was placed in an area of remote healthy myocardium, typically within the septum. 
5.3.4 Histology 
Staining was performed to assess the presence and extent of myocardial infarction (13). Animals 
were euthanized by exsanguination following an overdose of isoflurane anesthetic. The heart, 
with occluder attached, was swiftly removed. The coronary artery was occluded in the same 
position by re-inflating the occluder balloon. Evan’s blue dye (2%, 0.6ml) was injected 
retrogradely into the ascending aorta to delineate the area at risk. The heart was cut parallel to 
the atrio-ventricular groove in 1-mm thick slices. These were then incubated in 1% 
triphenyltetrazolium chloride (TTC) at 37°C for 20 min followed by 90 minutes in formalin. Viable 
myocardium stains red and necrotic area remains unstained by TTC. The slices were 
photographed using a color camera (Canon Powershot G12). The images were analyzed using 
ImageJ (Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, Maryland, USA). The 
area stained blue was defined as the remote area and the unstained area as the area at risk 
(AAR). The AAR was then divided into infarction (stained white), viable tissue with AAR (stained 
red), and remote tissue (stained blue). 
5.3.5 Statistical Analysis 
Continuous variables are expressed as mean ± standard deviation (SD). Normal distribution of 
the infarct size data was confirmed using by Normal plots and Shapiro-Wilk testing. A line of 
identity on a scattergram was drawn between each technique to allow a visual assessment of 
agreement. The Bland– Altman limits of agreement were also determined, with the difference in 
EF between techniques established for each subject along with the range of values within which 
95% of the differences were expected to lie (14). Results are presented as mean ± standard 
deviation. The mean differences in EF and infarction size were calculated between each 
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technique, and Student’s t-test was used to determine statistical significance. All tests were two-
tailed; p<0.05 was considered significant.  
 
5.4 Results 
5.4.1 Cine Assessment - SALLI Cine MR versus Cine MR 
Data was available for 24 rats. Average Heart rate over the entire exam was 330 (± 30). 
Representative images can be seen in Figure 5-3, and image quality was good or adequate in all 
cases. Image quality was comparable (p=0.56) between cine-MR (1.2 ± 0.4) and SALLI (1.4 ± 
0.5). Left ventricular function as measured by both methods was very similar. The EF by cine MR 
was 60.8 ± 12% and by SALLI it was 59.8 ± 12%. There was good correlation between both 
methods of measurement (r = 0.93). No significant difference was found between the methods of 
measurement (mean difference -0.5 ± 3%, p=0.42). The measured EF in both techniques is 




Figure 5-3. Comparison of SALLI-cine images in systole (a) and diastole (b) with Cine MR images in 










Table 5-1. The Mean Differences and Standard Deviation (SD) for Ejection Fraction between each 
Technique, Together with the Student’s t-test. The Bland–Altman Limits of Agreement are also Illustrated 
and Represent Ejection Fraction (%) 
 
 Mean Difference 






Cine – SALLI 0.9 ± 5 0.48 - 3.6, 5.4 38 - 82 
 
Image quality was similar between the pre- and post-contrast SALLI-cine images, and there was 




Figure 5-5. Comparison of (a) pre- and (b) post-contrast SALLI-cine images. 
 
5.4.2 Infarct Size Assessment - SALLI -LGE versus Histology 
Data was available for 24 Rats. Image quality was good or adequate in all cases (1.3 ± 0.5). 
None of the control rats had infarction detectable by SALLI-LGE. Infarcts were typically 
transmural as can be seen in Figure 5-6. 
 
Figure 5-6. SALLI-LGE images and Evan’s Blue/TTC stained slices of a heart that underwent 60 minutes of 
myocardial ischemia. The Infarct is stained white while the remote myocardium is stained blue. 
 
Infarct size was comparable between both methods, with infarct size by staining 23.5 ± 18% and 
by SALLI-LGE 21.9 ± 18%. No significant difference was found between the methods of 
measurement (mean difference 1.05 ± 5%, p=0.28). There was a good correlation between both 
methods of measurement (r = 0.95). Both staining and SALLI-LGE of which demonstrate a 





Figure 5-7. (a) Scatter plots with line of agreement and (b) Bland–Altman plots for comparisons between 
techniques. 
 
Table 5-2. The Mean Differences and Standard Deviation (SD) for Infarct Size Between Each Technique, 
Together with the Student’s t-test. The Bland–Altman Limits of Agreement Are Also Illustrated and 















Figure 5-8. Comparison of infarct size by staining (upper right) and by SALLI-LGE. 
 
 
5.4.3 Contrast Resolution 
Contrast resolution between infarcted and remote myocardium was measured in SALLI-LGE 
images as 53.2 ± 13%. Contrast resolution between infarct and blood pool was lower at 15.1 ± 
11 % in rats. A sample image can be seen in Figure 5-8. An advantage of SALLI is that the LV 
borders can be delineated from the Cine images in the same phase, and then copied to the LGE 
image to allow accurate measurement of infarct size and LV volumes.  
5.5 Discussion 
In a model of myocardial infarction, SALLI imaging was able to accurately assess LV function 
and characterise myocardial infarction in a time efficient fashion. LV systolic function was 
comparable to standard cine MRI across a wide range of LV function, from normal to severe LV 
impairment. SALLI-LGE was able to detect even small myocardial infarctions, and correctly 
identified normal myocardial tissue in control animals. 
Small animal contrast imaging has important differences relative to clinical scanning, resulting 
from the high heart rate of the animals. Diastole is much shorter, 20-30 ms, which allows fewer 
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lines of k space to be acquired per inversion. However, to allow time for adequate relaxation, the 
TR should be at least 2-3 times the T1 of myocardium (approx. 1100 ms at 3 T). The combination 
of long TR and multiple acquisitions could result in prolonged examination times (3). 
Modifications of the IR FLASH method have been proposed, with a different number of echoes 
(typically 4-16) acquired after each pulse and various gating strategies applied. These include 
magnetisation-prepared FLASH (7) for 2D imaging and a 3D sequence (15). An alternative to the 
IR method includes the Cine FLASH method, proposed by a number of groups (9, 16). This 
method offers the advantage of obtaining both functional and LGE data in one acquisition.  
SALLI offers the advantage of functional, LGE and T1 mapping in a single acquisition. To shorten 
acquisition duration, SALLI uses temporal undersampling and radial acquisition. However, this 
radial sampling leads to some loss of resolution in the fine details, as the periphery of k-space is 
more sparsely sampled. Using a clinical 3 T MR system with high-performance gradient system, 
individual slices could be acquired in 5-6 minutes, with T1 mapping, cine and LGE images of the 
whole heart in 40 minutes approximately. Acquisition times could be further reduced if a 
dedicated preclinical MR system with a faster gradient system were used.  
A number of methods for small animal MRI imaging have been developed on preclinical systems, 
offering very rapid cine and inversion-recovery LGE imaging at high resolutions. These include 
2D multislice imaging providing whole heart functional assessment in 6 minutes on a pre-clinical 
7T MRI system (8, 17). The use of multislice sampling allows the use of larger flip angles, which 
then results in higher signal-to-noise ratios. The use of a 3D sequence can provide even greater 
levels of SNR efficiency, offering rapid functional imaging (18) and whole heart T1 mapping (19).  
SALLI generates multiple IR images with different TIs. As most small animal LGE sequences 
take a number of minutes to generate each image, the optimal TI will vary following contrast 
injection for each slice. SALLI has the advantage of allowing the image with the best contrast to 
be selected for analysis, without the necessity to pre-select or change the selected TI. As images 
with multiple TIs are reconstructed, a Look-Locker sequence is not required to detemine optimal 
inversion time, offering potential time savings. However, a number of studies have found that at 
high field strength using higher doses of gadolinium contrast agent, the optimal TI is less 
important, and the imaging can be simply triggered every second or third heartbeat (8, 16). 
Contrast resolution using SALLI-LGE was adequate to accurately define myocardial infarction. 
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The value of 50.1% is comparable to the contrast resolution in other studies, which used higher 
field strengths and higher doses of contrast agent (8). 
As SALLI is a segmented image sequence, excellent ECG triggering and stability of the heart 
rate are required to allow image acquisition. In animals with large infarctions, there may be loss 
of ECG R-wave height, leading to challenges with recognition of the R-wave for triggering. 
Rigorous preparation of the electrical contact points of the ECG is required to minimize these 
issues. A dedicated small animal ECG system could allow for more sensitive ECG acquisition, or 
a self-gated sequence could overcome these difficulties. 
In contrast with some T1 mapping approaches, where the relaxation curve is influenced at 
intervals determined by individual heart rate, there is no heart rate dependency expected for T1 
values obtained with SALLI since there is a permanent readout of predefined duration (4000 ms 
in our example) that does not change with heart rate. 
SALLI generates three types of images from one image data set. Not only is this potentially time 
saving, the images of corresponding heart phases from all three modalities will spatially match 
each other. A direct comparison of findings is then possible without the need for further image 
registration. Imaging parameters can be adjusted to optimize the acquisition for the specific 
needs of the investigator. Acquisition duration (AD) and relaxation duration (RD) can be adjusted 
to the maximum expected T1 of the tissue of interest (e.g. 600 ms for post-contrast myocardium 
at 3 Tesla); b) temporal undersampling or low numbers of cardiac phases can be used where 
cine data is of less interest; c) increasing the NSA is helpful to increase SNR. For example, for 
the in-vivo images of the animal with myocardial infarction it would be possible to reduce the 
duration of post-contrast imaging by temporal undersampling or reducing the number of cardiac 
phases as the functional information is already available from the pre-contrast image. Increasing 
the number of signal averages would would allow improved spatial resolution. The imaging 
parameters could also be optimized for situations where myocardial changes are global rather 
than focal, such as in myocarditis. SALLI might be used to serially study acute myocardial injury 
in vivo in small animals, enabling parallel assessment of myocardial oedema and function and 




5.5.1 Study Limitations  
SALLI-LGE was not compared with conventional IR methods for infarct quantification. It was felt 
that quantification should be against the reference standard of histology, rather than other 
methods of LGE imaging. 
The sequence used has a resolution of 0.60 x 0.60 mm. This is reasonable resolution for rat 
myocardium (2-3 mm thick), but may miss very small or subendocardial infarcts. Higher spatial 
resolution could be achieved by use of a preclinical high-field MR system.  
 
5.6 Conclusions 
SALLI provides an acceptable alternative to conventional cine MR imaging and LGE methods for 
small animals. Both methods provided very similar results across a range of ventricular function 
and infarct size. Image quality was similar between both methods and interpretable in all cases. 
In addition, SALLI generates multimodal (in this case, cine MR, T1 maps and Inversion-Recovery 
prepared) images from the same dataset, with the advantage not only of potential time saving, 
but also of the comparison of findings without the need for further image registration. 
The multimodal approach of SALLI could speed up and facilitate the comprehensive and 
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Chapter 6 T1 Measurement in Acute Myocardial 
Ischemia/Reperfusion  
6.1 Abstract 
Myocardial ischemia causes local oedema, leading to prolongation of both T1 and T2. In clinical 
MRI, T2-weighted techniques are commonly used to visualize myocardial oedema. With standard 
MRI techniques, it is not possible to detect differences in oedema formation due to different 
reperfusion schemes such as preconditioning. Thus, these techniques cannot be used to 
compare the effects of reperfusion strategies. The aims were to study the acute T1 changes in-
vivo in a novel closed chest animal model of myocardial ischemia/reperfusion using T1 mapping 
and to test if this parametric approach could provide additional diagnostic information as 
compared to conventional MRI (1). 
Five groups of rats had an inflatable balloon coronary occluder surgically inserted via 
thoracotomy. They were allowed to recover for seven days. MRI was performed to obtain a 
baseline measurement of ventricular function. T1 mapping was performed using the Small-Animal 
Look-Locker Inversion Recovery (SALLI) technique. Short axis SALLI MR imaging was 
performed in the mid-ventricle distal to the occluder, with SALLI parameters as previously 
described. Without removing the animals from the scanner, the left coronary artery was occluded 
for 15, 30 or 60 minutes. Two groups of animals underwent three cycles of 5 minutes of 
preconditioning before 30 and 60 minutes of ischemia. Myocardial T1 measurements were 
repeated at 15-minute intervals during the experiment, throughout ischemia and the 90 minutes 
of reperfusion. MRI was performed on a whole-body 3.0-T MR unit with a dedicated rat coil.  
Myocardial T1 increased in the area-at-risk (AAR) within the first 15 minutes of ischemia. T1 
values increased slightly more with longer periods of ischemia but did not change with 
myocardial reperfusion. Preconditioning led to a more gradual and lesser increase in myocardial 
T1 in the AAR. Changes in T1 persisted at three and seven days. 
Myocardial T1 mapping can be used to study the changes in myocardial T1 in real-time in a model 
of ischemia/reperfusion. Changes in myocardial T1, likely reflecting myocardial water content, 
occur early following the onset of myocardial ischemia and values remain elevated for at least 
seven days following ischemia. Preconditioning appears to lead to less myocardial oedema, 
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which may explain some of its protective effects in myocardial ischemia. T1 mapping might 





In the myocardium, metabolic changes occur in the seconds following coronary occlusion. 
Anaerobic glycolysis becomes the sole source of high-energy phosphates, with lactate and 
protons as the principal end products (2). As described in more detail in chapter 6, myocardial 
cells have a low Adenosine Tri-Phosphate (ATP) content. Anaerobic glycolysis is unable to keep 
up with the metabolic demands of the cell (3). Intracellular ATP concentration decreases, and 
there is increased lactate production and a decrease in pH. A markedly decreased pH inhibits 
glycolysis and interferes with the residual metabolic pathways in the cell.  
The lack of ATP results in cessation of contraction. If ischemia is prolonged, the cell is unable to 
provide energy to maintain homeostasis, eventually leading to cellular bulging (4). In an attempt 
to control pH, the Na+/H+ exchanger in myocardial cells excrete excess H+ ions, leading to a Na+ 
influx (5), followed by Cl- and water. These factors combine with the failure of ATP-dependent 
cellular pumps, ATPases, such as the Na+/K+ ATPase, ATP-dependent Ca2+ reuptake, and active 
Ca2+ excretion. This results in Ca2+ overload, and eventually the opening of the mitochondrial 
permeability transition pore (MPTP). This pore opens in response to increased levels of calcium 
and the reactive oxygen species generated by the ischemic cell.  The combination of these and 
other changes lead to increases in cell membrane permeability, with disruption of intracellular 
electrolytes. The cell swells with the final event, the breakdown of the cellular wall.  
Reperfusion is the obvious treatment for coronary artery occlusion. Rapid reperfusion, either by 
thrombolysis or percutaneous revascularization, has been shown to reduce infarct size, and 
preserve left ventricular function, leading to improved survival (6, 7). However, the effects of 
reperfusion are complex. The limitation in ischemic injury by restoration of oxygen supply and 
normalization of pH are countered, in part, by reperfusion injury. Reperfusion injury was first 
described over 50 years ago (8) and is clinically manifested by arrhythmia, microvascular 
dysfunction, myocardial stunning, and myocyte death. The rapid normalisation of the pH outside 
the cell causes an extreme H+ gradient, leading to Na+/H+ exchange, and a further Na+ influx. 
This gradient also leads the passive Na+/ Ca2+exchanger to excrete Na+ for Ca2+, leading to 
further Ca2+ overload. The rapid changes of pH within the cell result in the opening of the MPTP, 
causing the mitochondria to swell and ultimately rupture. Mitochondrial rupture results in ATP 
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hydrolysis rather than production. The release of mitochondrial proteins and lack of ATP increase 
the likelihood of cell death. 
The acute injury described above can ultimately lead to various modes of cell death, including 
both necrosis and apoptosis. Necrosis is the predominant form of cell death in acute myocardial 
ischemia and is characterised by cellular swelling of the cell and its organelles, and the final 
breakdown of the cell membrane (9). Apoptosis is usually triggered by intracellular Ca2+ 
overload, leading to the release of apoptosis-inducing factor and ultimately to irreversible cellular 
dysfunction. Ca2+ overload also triggers H+ influx into the mitochondria, resulting in mitochondrial 
swelling and apoptotic changes (10). The breakdown of cell membranes and release of 
intracellular components leads to activation of an inflammatory response, which can lead to 
damage to neighbouring cells. This inflammatory response is accelerated and increased on 
myocardial reperfusion (11). 
In 1996, it was found that short bouts of ischemia and reperfusion (ischemic preconditioning) 
prior to prolonged myocardial ischemia (index ischemia) could reduce the size of myocardial 
(12). This original report of a reduction in myocardial infarct size in dogs was reproduced in other 
species, from rats (13) to pigs (14). It is of course not possible to perform ischemic 
preconditioning experiments in humans, however, both percutaneous coronary 
intervention  (PCI) and bypass surgery involve brief periods of myocardial ischemia. These have 
been used to study the effects of preconditioning and demonstrated a reduction in markers of 
myocardial damage (15) (16). The exact mechanism of the benefits remains to be elucidated. 
Indeed, whether preconditioning improves clinical outcomes has yet to be determined. 
In summary, myocardial ischemia-reperfusion leads to cellular electrolyte alterations, myocardial 
cell swelling and inflammation. T1 mapping is a powerful way to study changes in myocardial 
water content. As described in Chapter 3, myocardial "native T1" increases with myocardial water 
content or oedema. Quantitative in vivo measurement of water content using MRI is based on the 
proportionality of the MR signal to the number of protons in an image volume, which is again 
proportional to the water content in that volume. 
The aim of the present study was to assess in-vivo the sequential changes following myocardial 
ischemia and reperfusion. The closed-chest model developed in chapter 3 was used to study 
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dynamic changes in myocardial T1. Measurements were repeated to study the development of 
myocardial oedema during myocardial ischemia of varying durations and myocardial reperfusion. 
Imaging was repeated at 1 week following ischemia/reperfusion. Data were correlated with 
regional function using cine MR imaging and to the AAR as determined by Evan’s blue staining. 
 
6.3 Methods 
All procedures and experimental protocols were performed in accordance with the Federation of 
European Laboratory Animal Science Associations (FELASA) guidelines and recommendations, 
German federal law regarding the protection of animals and were approved by local authorities. 
6.3.1 Surgery 
The closed-chest model of myocardial ischemia/reperfusion as described in Chapter 3 was used 
to  avoid the surgical trauma and inflammation associated with open-chest models, and to allow 
ischemia/reperfusion to be induced with the animal in the bore of the MRI.  
6.3.2 Myocardial Ischemia Protocol 
Rats were anaesthetized with an initial dose of 4% isoflurane in an air/oxygen (4:1) mixture. A 
small incision was performed to locate the tip of the occluder. The tip was then attached to a 20G 
plastic cannula and extension tubing. The balloon could then be inflated and deflated without 
moving the animal in the bore of the scanner. One 26G iv cannula was placed in the tail to allow 
continuous potassium infusion to minimise cardiac arrhythmia (17). 
Anaesthesia was maintained using 1-2% isoflurane in an air/oxygen (4:1) mixture during the 
imaging. Body temperature was maintained at 37-38 °C using heating mats. The animals were 
positioned on a dedicated animal bed and positioned within the MRI coil. 
6.3.3 Imaging Protocol 
All MRI studies were performed on a 3-T clinical MRI system (Intera and Achieva, Philips 
Healthcare, Best, The Netherlands) equipped with a dedicated solenoid coil for rats. Animals 
were positioned in the coil head first and supine with ECG electrodes placed on the rats’ feet. 
Anaesthesia was maintained throughout the examination via inhalation of 1-2% isoflurane.  
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Using a long-axis set of cine images (2-chamber view and 4-chamber view) and a left ventricular 
(LV) cine short-axis stack (phases, 30; repetition time (TR), 6.8 ms; echo time (TE), 4.60 ms; flip 
angle, 15°; field of view, 80×64 mm; acquired voxel size, 0.4×0.4×1.5 mm; number of signal 
averages, 4; slices, 7; slice thickness 1.5 mm) the following parameters were assessed: LV 
ejection fraction, end-diastolic volume, end-systolic volume and cardiac output.  
After functional analysis, T1 parameters were measured before and after gadolinium contrast 
injection (gadobutrol [Gadovist]; Bayer-Schering AG, Berlin, Germany, 0.3 mmol/kg) at the same 
location in a mid-cavity short-axis slice using Small Animal Look-Locker Inversion Recovery 
(SALLI; acquisition duration, 4000 ms; relaxation duration, 4000 ms; phases, 4; flip angle, 10°; 
field of view, 56×56 mm; acquired voxel size, 0.6×0.6×2.4 mm; TR, 7.6 ms; TE, 3.1 ms; number 
of signal averages, 4; total acquisition time, 5 minutes 40 seconds).  
6.3.4 Coronary Occlusion Protocol 
Animals were divided into five groups, 15, 30 or 60 minutes of ischemia, and 30 and 60 minutes 
of ischemia proceeded by three cycles of 5 minutes of myocardial preconditioning. After baseline 
measurement, the left coronary artery (LCA) was occluded by inflating the balloon of the occluder 
with 0.2 ml of water and closing the 3-way stopcock. Ischemia was confirmed by ECG changes 
and localised hypokinesia on cine MR imaging. For the preconditioning groups, the artery was 
occluded for 5 minutes, followed by 5 minutes of reperfusion, which was repeated for three 
cycles. The LCA was then re-occluded, and after 15, 30 or 60 minutes of ischemia, the occluder 
balloon was deflated. SALLI was performed throughout, at baseline, and every 15 minutes during 
myocardial ischemia and for 90 minutes reperfusion following the reopening of the LCA. Cine MR 
imaging was repeated at the end of the protocol. To confirm successful reperfusion and estimate 
myocardial injury, SALLI-late gadolinium enhancement (SALLI-LGE) imaging was performed at 
the end of the protocol. 
Animals were re-imaged at three days and one week following ischemia/reperfusion including 
cine imaging and whole heart SALLI imaging for repeated T1 mapping and LGE imaging, as 




Figure 6-1. Outline of Experimental Protocol 
 
6.3.5 Image Processing 
Native (pre-contrast) and post-contrast T1 values were measured in the area at risk (AAR), the 
remote zone (typically the interventricular septum) and the blood pool (left ventricular cavity) from 
the SALLI T1 maps using Osirix v6.0 (Pixmeo SARL, Bernex, Switzerland) (18). The AAR was 
defined from the myocardial staining in the mid slice of the left ventricle. LV functional 
parameters were analysed in a CMR analysis software package (CMR42 version 3.4.1; Circle 
Cardiovascular Imaging Inc, Calgary, Alberta, Canada).   
6.3.6 Staining 
Staining was performed to confirm the presence of potential infarction and to assess the area-at-
risk in all animals similarly to methods previously described in Chapter 3 (19). Animals were 
euthanised by exsanguination following an overdose of isoflurane anaesthetic. Briefly, the heart 
with occluder attached was swiftly removed. The coronary artery was occluded in the same 
position by re-inflating the occluder balloon. Evan’s blue dye (2%, 0.6ml) was injected 
retrogradely into the ascending aorta to delineate the area at risk. The heart was cut parallel to 
the atrioventricular groove in 1-mm thick slices. These were then incubated in 1% 
triphenyltetrazolium chloride (TTC) at 37°C for 20 min followed by 90 minutes in formalin. Viable 
myocardium stains red and necrotic area remains unstained by TTC. The slices were 
photographed using a colour camera (Canon Powershot G12). The images were analysed using 
ImageJ (Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, Maryland, USA). The 
area stained blue was defined as the remote area and the unstained area as the area at risk 
(AAR). The AAR was then divided into infarcted (white) and viable (red) myocardium. 
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6.3.7 Statistical Analysis  
Continuous variables are expressed as mean ± standard deviation (SD). The Wilcoxon matched-
pairs signed rank test was used to assess the statistical significance of differences measured at 




Full datasets were available for 5, 5, 4, 5, and 4 animals in groups 1 to 5, respectively.  
 
6.4.2 Left Ventricular Function 
Baseline left ventricular function was measured at 69 ± 5%. At the end of each protocol, ejection 
fraction had reduced to 64 ± 4%. (15 minutes), 55 ± 6% (30 minutes), 47 ± 6% (60 minutes). 
 
Figure 6-2. Short axis T1 map of the left ventricle (LV) prior to myocardial ischemia demonstrating 








6.4.3 Infarct Size and Area at Risk 
The area at risk (AAR) was measured at 39.8% ± 12%. The AAR did not differ between groups 
(p=0.93). In the groups without preconditioning, infarct size was larger with increasing duration of 
ischemia (15 minutes 7.8% ± 3%, 30 minutes 35.0% ± 7%, 60 minutes 51.3% ± 7%). Infarct size 
tended to be smaller in both the 30-minute preconditioned groups (26.5% ± 6% versus 35.0% ± 
7%, p =0.097) and the 60-minute preconditioned group (42.5% ± 4% versus 51.3% ± 7%, p = 
0.079), however neither of these values reached statistical significance. 
 
Figure 6-3. Sequential colour T1 maps in one animal demonstrating the gradual evolution of changes in T1 
values in the anterior segment of myocardium (a) before, (b) after 15 minutes and (c) after 60 minutes of 
ischemia. 
 
6.4.4 Acute Alteration in T1 Values  
Baseline T1 values were 1049 ± 37 ms. Following 15 minutes of myocardial ischemia, T1 values 
in the area at risk increased significantly to 1205 ± 21ms (p<0.001) and remained significantly 
elevated at each stage of ischemia.  An example of the changes can be seen in the T1 maps in 
Figure 6-4. However, following the initial increase in myocardial T1, T1 values increased only 





Figure 6-4. Box plots show changes in native T1 between baseline, after 15, 30 and 60 minutes of 
myocardial ischemia.  
 
 
6.4.5 Effects of Myocardial Reperfusion. 
Myocardial reperfusion was not associated with a significant change in myocardial T1. Myocardial 
T1 remained elevated at approximately 1200ms during the 90 minutes of reperfusion, irrespective 

























baseline 15 minutes ischemia





Figure 6-5. Box plots comparing the native T1 after 60 minutes of ischemia with the various stages of 
reperfusion. 
 
6.4.6 Effects of Preconditioning 
Following three cycles of 5 minutes of ischemic conditioning, myocardial T1 in the area at risk 
increased more slowly to reach a peak of 1166 ± 40 at 60 minutes. The T1 value at each stage 
ischemia in the conditioned myocardium was significantly less than that of the non-conditioned 




Figure 6-6. Comparison of the effect of preconditioning on the rise in T1 values at each stage of ischemia. 
 
 
6.4.7 Findings at Three and Seven Days 
T1 values in the AAR remained elevated at three (1203 ± 79ms) and seven days (1240 ± 79ms). 
There were no significant differences between the T1 values at the end of reperfusion to those at 
three or seven days (p=0.06). These values were significantly higher than the T1 of remote 




Figure 6-7. Comparison of the native T1 values in the area at risk (AAR) and remote myocardium at three 
and seven days. 
 
 
6.4.8 Post-Contrast T1 Values 
Following injection of iv gadolinium contrast agent, T1 values in the AAR was significantly shorter 
than that in remote myocardium at both three (392 ± 51 vs 521 ± 71) and seven days (368 ± 111 
vs 500 ± 134). A post-contrast colour T1 map can be seen in Figure 6-8. There was no significant 




Figure 6-8. Post contrast T1 map demonstrating a large anterior segment of myocardial injury (arrows) in 





Figure 6-9. Comparison post-contrast T1 values in the area-at-risk (AAR) and remote myocardium at three 




In this study, we found that the T1 values in ischemic myocardium change in the first 15 minutes 
following the onset of myocardial ischemia. Myocardial T1 in the AAR was only slightly longer 
after 60 minutes of ischemia that after 15 minutes of ischemia. These values remain elevated 
during the first 90 minutes following myocardial reperfusion, irrespective of the duration of the 
index ischemia. Preconditioning lead to a more gradual increase in myocardial T1 in ischemic 
myocardium, and was significantly lower in preconditioned ischemic myocardium than in non-
conditioned myocardium. T1 values remained elevated in the AAR at both three and seven days 
and were significantly lower in the AAR following the injection of gadolinium contrast agent that in 
remote myocardium at both of these stages. 
Using the novel animal model, we were able to study the acute development of myocardial 
oedema in real-time. Following just 15 minutes of myocardial ischemia, native T1 values were 
significantly increased, indicating an early increase in myocardial water content. Control of water 
content is tightly regulated aspect of cellular homoeostasis. Following the onset of ischemia, 
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myocardial cells are unable to control water content, leading to myocardial oedema, both 
intracellular and extracellular. This early swelling has been demonstrated to be predominantly 
intracellular (20). Following reperfusion, there is an increase in interstitial oedema (20), thought 
to be due to reactive hyperaemia and leakage from damaged capillaries.  
CMR has a number of properties that allow it to characterise myocardium, and to evaluate 
myocardial water content. T2 weighted sequences have been used to demonstrate increased 
myocardial water content and oedema in both ischemic myocardium (21, 22) and myocarditis 
(23). T2 weighted imaging can be technically challenging, and, like LGE does not offer 
quantitative measurements to allow comparison between subjects and different studies. These 
studies have recently been supplemented by newer studies using T2 mapping techniques that 
demonstrated similar increases in T2 values in both myocardial ischemia (24, 25) and myocarditis 
(26). In fact, a recent study found that T2 values were closely related to the changes in 
myocardial water content following myocardial ischemia (27). 
Similar to T2 values, it has been known for over thirty years that T1 increases in ischemic 
myocardium (28, 29).  Changes in both T2 and native T1 values have been validated by 
microspheres in dog models of myocardial ischemia (24), with excellent agreement between both 
measurements to detect the myocardial AAR. T1 mapping has the advantage that native and 
post-contrast values can be used to study changes the composite water signal from interstitium 
and myocytes (native values), whereas changes in post-contrast T1 reflects the extravascular 
compartment. 
We did not notice a significant change in T1 values following myocardial reperfusion, as might be 
expected from earlier studies. In the case of the briefer periods of ischemia, the reactive 
hyperemia may have been balanced by a return to baseline of normal cellular and intracellular 
oedema (30). It may also be that our study was underpowered to detect differences in myocardial 
oedema at reperfusion after 60 minutes of ischemia. 
We found that three cycles of 5 minutes of preconditioning with 5 minutes of reperfusion led to a 
more gradual increase in myocardial T1, with peak T1 values not reaching that of remote 
myocardium. Lower  T1 values are in keeping the finding that preconditioning reduced myocardial 
oedema in studies of both rats (31) and pigs (32).  It is thought that one of the actions of 
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preconditioning is to make myocardial cells more resistant to membrane rupture when 
challenged with hypotonic media (33). Alterations in channels involved in cell volume regulation, 
therefore, might be involved in the cardioprotection achieved by ischemic preconditioning. 
Preconditioning is thought to stimulate the release of a large number of substrates, including 
adenosine, acetylcholine, catecholamines, bradykinin, endothelin and opioids. For example, 
adenosine, formed from the breakdown of ATP in ischemic cells, has been demonstrated to 
cause preconditioning in humans (34). These substrates, in turn, are thought to activate a 
number of critical pathways. These include the activation of protein kinases, including protein 
kinase C, and the opening of ATP-dependent potassium channels. For example, opening the 
mitochondrial ATP-dependent potassium channels can lead to reduced cardiac output and 
improved myocardial survival (35). Ultimately, these pathways inhibit the opening of the 
mitochondrial permeability transition pore. It thought that the opening of this pore leads to both 
cellular apoptosis and necrosis. 
Preconditioning has not only demonstrated reduced oedema in myocardial cells, but it has also 
been found to reduce cerebral oedema as a result of cerebral artery occlusion (36). It is thought 
that channels involved in cell volume regulation are activated, preventing cell rupture and death 
(37). Another possibility is that preconditioned cells have less accumulation of lactate and 
phosphate catabolites during ischemia, as these have been reduced by the episodes of 
preconditioning. Lower level of these catabolites results in less osmotic cellular swelling during 
reperfusion (32). It has been proposed that acutely oedematous cardiac cells are more prone to 
cell death following reperfusion (38), which would support a strategy of the reduction of acute 
cellular oedema. Our finding that preconditioning was associated with a smaller increase in 
myocardial T1 supports the conclusions of previous studies that found a preconditioning resulted 
in reduced cellular oedema. 
Elevated T1 was persistent both three and seven days after index ischemia. A recent study using 
T2 mapping in a pig model of myocardial ischemia (27) found that the formation of oedema was a 
bimodal process, with an early increase in myocardial water content, followed by a decrease on 
day one. Water content increased again on day four before reaching a peak on day seven. We 
found that T1 was slightly, but not significantly, lower on day three than at day seven. We did not 
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measure T1 values at day one following ischemia, and cannot therefore confirm acute variations 
in T1 values following myocardial ischemia. 
6.5.1 Study Limitations  
Our model typically creates an AAR of 42%, with the AAR involving predominantly the anterior 
and anterolateral segments of the heart. As the rat has no collateral vessels, the AAR is 
transmural. However, the size of the rat heart and resolution of our imaging mean we are unable 
to determine transmural variations in T1 values. 
 
6.6 Conclusion 
In a small animal model of myocardial ischemia, native T1 values increase early following the 
onset of myocardial ischemia. Longer periods of ischemia resulted in slightly higher T1 values; 
however, myocardial reperfusion was not associated with an increase in T1. Native T1 values 
remained elevated at both three and seven days following myocardial ischemia. Preconditioning 
led to a more gradual increase in myocardial T1, with values not reaching those of non-
conditioned myocardium, suggesting that preconditioning leads to a reduction in myocardial 
oedema. T1 mapping might serve as a non-invasive tool for assessing the immediate impact of 
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Chapter 7 Hyperpolarised Metabolic MR Imaging of Acute 
Myocardial Changes and Recovery upon Ischemia-Reperfusion 
in a Small Animal Model 
7.1 Abstract 
The aim of this study was to implement hyperpolarised MR imaging in an animal model of 
ischemia/reperfusion and to assess in-vivo the regional changes in pyruvate metabolism within 
the first hour and at one week upon a brief episode of coronary occlusion and subsequent 
reperfusion. 
All animal experiments were performed in adherence to the Swiss law of Animal Protection and 
approved by the Zurich cantonal veterinary office. A closed-chest rat model was implemented 
using an inflatable balloon secured around the left coronary artery. The rats were placed in an 
MR system 5-7 days after surgery. [1-13C]pyruvate was polarised using a home-built multi-
sample hyperpolariser. Rats were injected with hyperpolarised pyruvate at five stages: baseline, 
on reperfusion after 15 minutes of coronary occlusion, after 30 and 60 minutes and 1 week later. 
The conversion of pyruvate to lactate and bicarbonate was imaged using dedicated MR 
sequences alongside wall motion and delayed enhancement imaging. Following imaging, the 
heart was removed and stained to delineate the area-at-risk. Differences between AAR and 
remote myocardium were assessed using a repeated measures analysis of variance (ANOVA) 
and a posthoc  Bonferroni multiple comparison test. 
Data were collected in 12 animals. Occlusion led to hypokinesia of the anterior or anterolateral 
segments of the myocardium. On reperfusion, the average lactate/bicarbonate area-under-the-
curve ratio increased in the AAR relative to baseline (from 1.93±0.5 to 3.01±0.7, p<0.001) and 
was significantly higher compared to the remote area (1.91±0.4, p<0.001). In the 60 minutes 
following occlusion the lactate/bicarbonate ratio in the AAR recovered but was still elevated 
relative to the remote area. One week after ischemia/reperfusion no difference between the AAR 
and the remote area could be detected. 
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Hyperpolarised metabolic MR imaging successfully detects acute changes in [1-13C]pyruvate 
metabolism following ischemia/reperfusion. Myocardial metabolism was abnormal in the area-at-






7.2 Introduction  
Myocardial ischemia occurs when myocardial oxygen supply is insufficient to maintain normal 
metabolism. Increasing levels of ischemia will lead to progressive changes, beginning with 
diastolic dysfunction, systolic dysfunction, electrographic changes, and finally angina, a process 
known as the ischemic cascade (1). If the ischemia is severe, homeostasis is compromised. 
Prolonged ischemia will ultimately lead to cell death unless normal perfusion returns. 
Currently, ischemia is predominantly detected indirectly, using electrical changes during ECG 
stress testing (2), relative changes in perfusion using nuclear or CMR imaging (3, 4), or abnormal 
myocardial function in stress echocardiography (5) or CMR (5). Although PET does have a role 
in quantifying metabolism, PET predominantly measures perfusion and accumulation of a tracer, 
but it is unable to detect downstream metabolites from the injected tracer. As metabolic changes 
are an initial event in the ischemic cascade, a method of detecting abnormal myocardial 
metabolism might allow the improved detection of myocardial ischemia. 
Indeed, until now, there was no method to detect these metabolic alterations in-vivo. In addition, 
the metabolic changes of ischemia and subsequent reperfusion could not be studied in-vivo. 
Myocardial reperfusion can paradoxically compound the biochemical and metabolic changes that 
occur in ischemia, with the best-established manifestation of this being myocardial stunning - 
prolonged post-ischemic dysfunction of viable tissue salvaged by reperfusion (6). The lack of a 
tool to assess reperfusion injury in patients has prohibited the development of interventional or 
pharmacologic strategies to successfully prevent or at least minimise reperfusion injury in 
humans.  
Hyperpolarised MR has emerged as a promising tool to address the limited sensitivity of MR 
imaging when probing metabolic processes. It provides the possibility to study the rapid changes 
in metabolism during myocardial ischemia and reperfusion, enabling the in-vivo analysis of 
myocardial injury with different reperfusion strategies. Using the dissolution Dynamic Nuclear 
Polarisation (DNP) principle (7), the MR sensitivity is increased by a factor of >10,000 allowing 
the study of metabolic changes occurring in the heart in real-time. Some studies have 
demonstrated the ability of hyperpolarised MR to interrogate substrate metabolism in the ex-vivo 
and in-vivo heart under various conditions (8-13). Most have used non-selective or slice-selective 
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MR spectroscopy to study global changes in the heart. More recently, also metabolic images 
have been obtained to assess regional differences in metabolism in-vivo in the pig following 
myocardial ischemia (15) and in the isolated perfused rat heart (16). However, there have been 
no in-vivo studies demonstrating regional differences in metabolism following 
ischemia/reperfusion in the acute and recovery phase so far. 
In relation to hyperpolarised MR studies of the heart, pyruvate has been of main interest given its 
central role at the crossroads between glycolysis and oxidative phosphorylation and because of 
its relatively long relaxation times which allowing observation of metabolic turnover. With 
adequate oxygen supply, pyruvate is irreversibly metabolised in the mitochondria to CO2 and 
Acetyl-CoA. Carbon dioxide is rapidly converted to bicarbonate (HCO3-) to allow for CO2 
transport and to maintain cellular pH. The presence of HCO3- therefore, reflects the formation of 
Acetyl-CoA, which then enters the Krebs cycle. Reduced bicarbonate signal may be due to 
reduced flux through the Krebs cycle, a switch from the metabolism of carbohydrates to oxidation 
of fats or ketones, or a combination of both of these two factors. Without sufficient oxygen 
supply, pyruvate is metabolised to lactate. This process generates a small amount of ATP and, 
more importantly, NAD+, which is required for glycolysis. Therefore, regional ischemia should be 
marked metabolically by reduced HCO3- and increased lactate in the area affected or the area-at-
risk (AAR). This lactate/bicarbonate ratio has been suggested as a marker of ischemia, as 
ischemia inhibits pyruvate metabolism to bicarbonate while simultaneously increasing tissue 
lactate (17).  
The aim of the present study was to implement and validate hyperpolarised MR imaging in an 
animal model of ischemia/reperfusion and to assess in-vivo the regional changes in pyruvate 





All animal experiments were performed in adherence to the Swiss law of Animal Protection and 
approved by the Zurich cantonal veterinary office.  
 
7.3.1 Surgery 
To avoid the surgical trauma and inflammation associated with open-chest models, and to allow 
ischemia/reperfusion to be induced with the animal in the bore of the MRI scanner, a closed-
chest model of myocardial ischemia/reperfusion was implemented as described in Chapter 3 
(17).  
 
7.3.2 Animal Preparation  
Rats were anaesthetized with 4% isoflurane in an air/oxygen (4:1) mixture, endotracheally 
intubated and ventilated. Anesthesia was maintained using 1-2% isoflurane. Body temperature 
was kept at 37-38 °C using a warm water heating mat. The occluder tubing was located and the 
tip attached to a 20G plastic cannula and extension tubing. Two 26G i.v. cannulae were placed in 
opposite sides of the tail, one to allow injection of the DNP substrate, one for continuous glucose 
infusion (15 mg/kg/min glucose and 10 mmol/kg/min potassium) to keep blood glucose levels 
constant (18). Blood glucose was measured following each experiment (OneTouch Ultra 2, 
LifeScan, Switzerland).Anesthesia was maintained using 1-2% isoflurane in an air/oxygen (4:1) 
mixture during imaging. Body temperature was maintained at 37-38 °C using a warm water 




Figure 7-1. Initial setup of the Rat with temperature probe, ECG pads, iv canulae and occluder tubing in 
place. The warming mat is then placed over the animal to maintain a constant temperature. 
 
7.4 Hyperpolarisation 
A home-built multi-sample DNP polariser (19) was used to polarise samples consisting of 25.4 
μL [1-13C]pyruvic acid (Sigma-Aldrich) and 13.5 mM trityl radical (tris(8-carboxyl-2,2,6,6-tetra(2-
(1-hydroxyethyl))-benzo[1,2-d;4,5-d’]bis(1,3)dithiole-4-yl) methyl sodium salt)) (GE Healthcare), 
doped with 1.5 mM Dotarem (Guerbet, Paris, France). After 90 minutes of polarisation at 1.3 K, 
the sample was dissolved in 8 mL Tris buffer and neutralized with sodium hydroxide, resulting in 
a 44-mM [1-13C]pyruvate solution at room temperature. Liquid state-polarisation of 
hyperpolarised [1-13C]pyruvate was measured as 18.7 ± 2% at t = 30 sec after dissolution in 
phantom experiments and extrapolated back to t = 0 sec resulting in polarisation values of 
36.4±5% for measured T1 values of 45.2 ± 4 sec at 9.4T. To perform metabolic imaging, 1.4 mL 




7.4.1 Imaging Protocol 
MR imaging experiments were performed on a 9.4T Bruker Biospec 94/30 small animal MR 
system (Bruker BioSpin GmbH, Karlsruhe, Germany). A birdcage dual 1H/13C coil (Rapid 
Biomedical, Wurzburg, Germany) was used for excitation, and a 13C surface coil with sensitivity 
area 40 x 30 mm2  from the same vendor was placed over the thorax for signal reception.  
Initially, axial and longitudinal scout images were acquired to plan the 2-chamber long-axis view. 
The animal was repositioned to locate the heart in the isocentre of the scanner. A 4-chamber 
long-axis view was then acquired perpendicular to the 2-chamber orientation, after which a series 
of short-axis cine MR images was obtained perpendicular to the LV long-axes from the 2- and 4-
chamber images. Cine MR images were acquired using an ECG-triggered Fast Low Angle Shot 
(FLASH) sequence with TR/TE of 8/1.9ms, flip angle 15°, FOV 60x60 mm2, matrix = 192x192, 
signal averages = 4 and spatial resolution 0.31x0.31x1.27 mm3. 
Before 13C image acquisition, first order shimming was performed by minimizing the water line 
width using a localized spectroscopic pulse sequence with a voxel covering the left ventricle. The 
same pulse sequence was used to determine the frequency of the water peak, which then was 
scaled to adjust the 13C centre frequency on pyruvate in the heart. The 13C pulse angle was 
calibrated on a phantom consisting of 5M 13C-labeled sodium acetate solution doped with 0.5 M 
gadolinium-DOTA, which was attached to the surface coil. 
Metabolic data, metabolic data were acquired with a multi-band radiofrequency pulse in 
combination with a multi-echo single-shot EPI readout as described previously (20). In contrast to 
the original publication partial Fourier acquisition with 69% coverage in phase-encode direction 
and a smaller field of view (FOV) were used to allow for shorter echo and readout times and 
higher resolution. Seven echoes were acquired with an initial echo time of 5.31 ms and an echo 
time increment of 383 μs. The EPI readout used a matrix of 96 x 22 and a FOV of 60 x 40 mm2. 
Two-fold oversampling in readout direction was applied which resulted in an in-plane resolution 
of 1.25 x 1.25 mm2. The slice thickness was 5 mm. Each readout was triggered to end systole, 
and the seven readouts were repeated every 1.5 s during a total scan duration of 5 min. 
To assess the reproducibility of the setup, two repeat measurements separated by 20 minutes 
were performed in ten healthy rats prior to the actual study.  
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7.4.2 Coronary Occlusion Protocol 
After the baseline measurement in each operated rat, the left coronary artery (LCA) was 
occluded by inflating the balloon of the occluder with 0.2 mL of water and closing the 3-way 
stopcock. Ischemia was confirmed by ECG changes and localized hypokinesia on cine MR 
imaging. After 15 minutes of ischemia, the occluder balloon was deflated. Metabolic imaging was 
performed at four stages, at baseline, immediately after reopening of the LCA, and at 30 and 60 
minutes. Cine MR imaging was performed at each of these stages. To confirm successful 
reperfusion and estimate myocardial injury, late gadolinium enhancement (LGE) imaging was 
performed at 60 minutes. 
A subgroup of 8 animals was planned to be re-examined one week following 
ischemia/reperfusion including metabolic, cine and LGE imaging, as described above.  The 
overall experimental protocol is illustrated in Figure 7-2. 
 
Figure 7-2. Study timeline indicating the imaging experiments performed at each step. 
 
7.4.3 Image Processing 
Metabolic images were reconstructed using the IDEAL approach (21) encoding pyruvate, lactate, 
bicarbonate, pyruvate hydrate and alanine resonances. After metabolite separation, EPI 
chemical shift was corrected for each metabolite frequency. The images were normalized to 
noise (determined from a late dynamic when all hyperpolarised signal has decayed) and then 
adjusted for the sensitivity of the 13C surface coil using data acquired in a uniform 3M 13C urea 
disk phantom. For display, metabolic maps of pyruvate, lactate and bicarbonate were overlaid 
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onto 1H reference images. Average signals within four myocardial sectors were computed after 
applying a time-averaged phase correction term for each pixel to remove phase effects due to 
spatially varying magnetic field inhomogeneity and to add the pixels within each ROI in phase. 
The signal was masked by drawing the blood pool and the four myocardial segments on the 1H 
reference image. Signal intensity-time curves of pyruvate, lactate and bicarbonate were 
integrated to obtain the area-under-the-curve (AUC). 
Left ventricular function and LGE were assessed using cmr42 (Circle CVI, Calgary, Alberta, 
Canada). Enhanced regions were determined using the full-width-half-maximum thresholding 
method. Four regions were evaluated, lateral, inferior, septal, and anterior. Regional wall motion 
and systolic wall thickening were scored using a five-point grading scale: 1, normal; 2, mildly 
hypokinetic; 3, severely hypokinetic; 4, akinetic; and 5, dyskinetic. LGE was quantified on the 
basis of the relative area of hyperenhancement in the 4 midventricular slices of each region using 
the following scale: 0 - no LGE; 1 - 0-33% LGE; 2 - 34-66% LGE; 3 - 67-100% LGE. 
7.4.4 Staining 
Staining was performed to define myocardium as remote myocardium or area-at-risk (AAR) and 
to detect myocardial infarction. Full details are presented in the supplemental content. The four 
myocardial segments used in the analysis of the metabolic maps, wall motion and LGE data 
were classified as AAR or remote area according to the staining results. Similar to LGE, staining 
was quantified on the basis of the area of AAR to remote myocardium in the midventricular slice 
of each region using the following scale: 0 - no AAR; 1 - 0-33% AAR; 2 - 34-66% AAR; 3 - 67-
100% AAR. 
7.4.5 Statistical Analysis  
Continuous variables are expressed as mean ± standard deviation (SD). A line of identity on a 
scattergram was drawn between each measurement to allow a visual assessment of agreement. 
The Bland–Altman limits of agreement were then determined. Statistical significance between 
AAR and remote area and between different time points was assessed using a repeated 
measures analysis of variance (ANOVA) and a posthoc Bonferroni multiple comparison test. A 





In the 10 healthy animals used to test reproducibility, mean ± standard deviations of the 
difference in the area-under-the-curve of the lactate/bicarbonate ratio between injections were 
3.5±6%, 7.0 ± 12%, 5.1 ± 12% and 0.5 ± 10% for anterior, septal, inferior and lateral myocardial 
segments, respectively. Bland Altman plots and regression lines can be seen in Figure 7-3. 
Ischemia/reperfusion data were collected on 12 animals. Reperfusion was successful in 11 of 12 
animals as evidenced by recovery of systolic function, and ECG changes. One animal without 
reperfusion developed further ST segment/R wave changes on ECG and continued to have 
severe localized hypokinesia. On LGE imaging, a central core of microvascular obstruction was 
observed. This animal died at the end of the initial imaging protocol and was not included in the 
analysis as the myocardium was not reperfused following ischemia. One other animal had 
evidence of infection around the occluder and heart and was also excluded.  
Myocardial systolic function was normal in all regions before coronary occlusion (wall motion 
score 1.03 ± 0.1). All animals developed akinesia or severe hypokinesia of the anterior and 
lateral regions of the myocardium (3.4 ± 1.1). Function remained unchanged in remote regions 
(1.1 ± 0.3). Systolic function in the AAR improved on reperfusion (1.95 ± 0.9) and had recovered 
to near normal by 60 minutes (1.5 ± 0.5). Blood glucose at the end of scanning was 15.8 ± 1 




Figure 7-3. Scatter plots with line of agreement and Bland–Altman plots for comparisons between each 





Figure 7-4. Example images at the five-time points in one animal. Left (a): Cine images show reduced 
systolic wall thickening in the AAR (anterior and lateral walls - arrow) on reperfusion. Middle (b): Metabolic 
maps of lactate, bicarbonate and lactate/bicarbonate (lac/bic) ratio (masked by myocardial segments used 
for analysis). In the AAR, the lactate/bicarbonate ratio is increased. Right (c,d): Cine image and schematic 
depiction of the four myocardial segments (AAR-red, remote myocardium – blue). (e) Evan’s Blue staining 
dividing the myocardium into AAR – red (involving anterior and lateral segments), and remote myocardium 
– blue (septal and inferior). (f) Late gadolinium enhancement imaging demonstrates an area of 
hyperenhancement and thickening. 
 
Metabolic images of hyperpolarised [1-13C]pyruvate and its metabolites demonstrated sufficient 
signal-to-noise ratio (SNR) and spatial distribution at baseline in all animals. Peak pyruvate SNR 
in the left ventricular blood pool across all subjects was 53.7 ± 36 while lactate and bicarbonate 
and alanine SNR averaged over the myocardium were 13.7 ± 6, 8.4 ± 3 and 4.9 ± 1 respectively. 
At baseline, the lactate/bicarbonate AUC ratio was 1.79 ± 0.5. Examples of metabolic maps and 




Figure 7-5. Assessment of segmental changes in metabolism and myocardial function (same animal as in 
Figure 2). For each time point, systolic function on cine MR; lactate, bicarbonate, and lactate/bicarbonate 
ratios are quantified as derived from the area-under-the-curve (AUC) of the signal intensity time curves as 
indicated. Myocardial staining demonstrates the area-at-risk.  
 
The average time between reopening and injection of [1-13C] pyruvate was 3.0 ± 1 min. At this 
time point, the lactate/bicarbonate AUC ratio in the AAR increased relative to baseline (from 1.93 
± 0.5 to 3.01 ± 0.7, p<0.001) and was significantly increased relative to the ratio of the remote 
area (1.95 ± 0.4, p<0.001) (Figure 7-7). 
The lactate/bicarbonate ratio in the AAR gradually recovered in the measurements at 30 (2.27 ± 
0.5) and 60 minutes (2.17 ± 0.5) but was still elevated compared to the remote area (1.61 ± 0.5, 
p<0.01)  (Figure 7-7). 
In the animal without successful reperfusion, the lactate/bicarbonate ratio continued to increase 
at 30 and 60 minutes (2.92 on reperfusion to 5.72 at 60 min), suggesting continued anaerobic 
glycolysis and a lack of resumption of oxidative phosphorylation. The animal with infection had a 
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globally elevated lactate/bicarbonate ratio on the first measurements, which persisted in the 
examination at 1 week.  
 
Figure 7-6. Left: Example signal intensity-time curves of pyruvate in the blood pool (green), lactate and 
bicarbonate in the AAR (red, orange) and remote myocardium (blue, cyan). Middle: AUC values for lactate 
and bicarbonate in the AAR (red, orange) and remote myocardium (blue, cyan). Right: Lactate/bicarbonate 
ratio as a function of time (vertical). On reperfusion, lactate/bicarbonate ratio is increased in the area-at-risk 
(dark red) vs. remote myocardium (dark blue) but reduces at 30 and 60 min indicating normalization of 
metabolism after the transient ischemic event. 
 
Two of the eight planned animals died in the week following ischemia-reperfusion. The six 
remaining were scanned as intended. One week after the ischemic episode, the 
lactate/bicarbonate ratio in the AAR was not significantly different from the remote area (Figure 
7-7). LGE imaging revealed small areas of hyperenhancement in 3 of the 6 animals (grade 0.7 ± 
0.8 of the three anterior regions involved). This enhancement occurred solely in the area at risk 
and was not present in the remote myocardium (Figure 7-7). 
The myocardial AAR of the entire heart, as determined by Evan’s blue staining, was 30.3 ± 8% 
and involved the anterior and lateral segments exclusively (grade 2.25 ± 0.7). Very small infarcts 
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were detected in 8 out of 10 animals during histology with an average volume of 2.5 ± 2% of the 
whole myocardium. 
 
Figure 7-7. Summary of study findings. Top: Pooled AUC lactate (left) and bicarbonate (right) data of all 
animals. Bottom left: The AAR lactate/bicarbonate ratio increased following 15 min of ischemia, remained 
abnormal during the following 60 min and returned to base level at one week. Bottom right: The figure 
shows localized hypokinesia in the AAR following ischemia and its recovery with time. The AAR had small 
areas of hyperenhancement in 3 of 6 animals 1 week after ischemia/reperfusion. Mean values (± SD) are 





7.6 Discussion  
In this work, the acute changes in the metabolism of pyruvate and its recovery were studied in an 
in-vivo model of myocardial ischemia-reperfusion. On reperfusion, the lactate/ bicarbonate signal 
ratio was significantly increased in the AAR, indicating a reduction in oxidative metabolism and 
increased anaerobic metabolism. In the hour after reperfusion, pyruvate metabolism in the AAR 
demonstrated the dynamic changes with a decrease in the ratio of anaerobic to oxidative 
metabolism towards the baseline. At 1 week, no sequelae in pyruvate metabolism could be 
detected within the spatial resolution of our images, indicating metabolic recovery. 
There have been a number of spectroscopic studies using hyperpolarised pyruvate to assess 
myocardial metabolism in ischemia e.g. (22). The present study used hyperpolarised MR imaging 
to investigate the regional differences at multiple time points after myocardial ischemia-
reperfusion. This allows the in-vivo visualization of the spatial distribution of metabolic changes 
across the myocardium.  Similar to ex-vivo studies, an increase in the lactate to bicarbonate ratio 
was detected in the AAR on reperfusion. In keeping with a previous large animal study (15), the 
metabolic change persisted for the first hour, even when the systolic function had returned to 
normal.  
In the animal without successful reperfusion, the lactate/bicarbonate ratio continued to increase, 
suggesting impaired oxidative phosphorylation with continuing anaerobic glycolysis. The return 
towards a baseline lactate/bicarbonate ratio in the other animals suggests that perfusion was 
adequate to meet the metabolic needs of the myocardium. Of course, there could have been 
small areas of impaired perfusion that were below the resolution of our LGE imaging technique. 
This raises the issue of how perfusion can interact with myocardial metabolism.  It is known that 
a coronary stenosis leading to inadequate myocardial perfusion will result in diastolic dysfunction 
and then systolic dysfunction before becoming clinically apparent via ECG changes and finally 
angina, known as the ischemic cascade. The development of hyperpolarised imaging now 
presents a means of studying the role of metabolism in this process (1). Although a recent 
hyperpolarised study did not detect changes in acetate metabolism during dobutamine stress 
testing (23), this area of research remains to be fully explored.  
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Studies on isolated perfused rat hearts have provided data before and during permanent 
coronary occlusion. However, in these studies the occluded artery resulted in a confounding 
perfusion defect in the AAR. Correcting for the change in perfusion in these studies allowed 
increased lactate signal intensity and increased lactate/bicarbonate ratio in the AAR to be 
demonstrated. It is nevertheless noted that the hyperpolarised tracer may not have reached the 
central core of the ischemic zone, as myocardial collaterals are limited. Accordingly, metabolic 
changes may have reflected inadequate perfusion in the ischemic border zone.  
A previous study using an ex-vivo model of 10 minutes of global ischemia demonstrated virtually 
no production of bicarbonate in the first 90 seconds of reperfusion (16), with a rapid increase in 
production following 10 minutes of reperfusion. In contrast to our work and other studies (22, 24), 
this study demonstrated a bicarbonate signal was many times greater than the lactate. The 
discrepancy between this ex-vivo model and our data is attributed to the fact that the perfused 
heart was supplied with 2 mmol pyruvate as a sole energy source while, in this in-vivo study, 
alternative substrates were available to the myocardium. 
In the present study the metabolism, as measured by the lactate/bicarbonate ratio, had 
recovered to normal at 1 week. Of the eight animals planned for the one-week follow-up 
experiments, two died prematurely. Metabolic recovery may be associated with increased 
myocardial survival. However, as these animals had small infarctions on tetrazolium chloride 
(TTC) staining and near-normal systolic function, it seems likely that these animals died of 
cardiac arrhythmia rather than progressive heart failure.  
Early reperfusion is the goal of therapy in patients with ST-elevation myocardial infarction. 
Reopening an acutely occluded coronary artery reduces the size of myocardial infarction, but is 
also associated with transient contractile dysfunction, arrhythmias and increased myocardial 
enzyme release (25) due to rapid metabolic processes summarized as reperfusion injury. So far, 
there is no method available allowing for assessing the magnitude of reperfusion injury in-vivo in 
patients. Hyperpolarised metabolic MR imaging provides the possibility to study the rapid 
changes in metabolism during myocardial reperfusion, enabling the in-vivo analysis of myocardial 
injury with different reperfusion strategies.  
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Other clinical possibilities include the detection of stress-induced myocardial ischemia, using the 
injection of hyperpolarised tracers at peak stress, avoiding the need for gadolinium contrast 
agents. As viable myocardium is metabolically active, hyperpolarised MR imaging could offer an 
alternative to LGE imaging or PET imaging in the detection of viable myocardium. Although the 
increased signal offered by hyperpolarisation could provide superior spatial resolution to PET, it 
would remain challenging to improve on the spatial resolution currently available in clinical LGE 
imaging. 
 
7.6.1 Study Limitations  
Rather than merely demonstrating decreased metabolism in infarcted tissue, the aim of this study 
was to investigate the changes in viable myocardium. Even with 15 minutes of ischemia, very 
small volumes of myocardial infarction (2.5 ± 2%) could be detected in some animals during 
histology. However, these small infarct volumes were not detectable with the spatial resolution of 
the metabolic imaging sequence. 
As the experiments took place during the day, the animals were fasting. During fasting, pyruvate 
supplies only a small amount of carbon for the Krebs cycle. To increase the flux via pyruvate 
dehydrogenase, the rats were provided with an i.v. glucose infusion. In healthy myocardium, 
hyperinsulinemia and hyperglycemia increase both glycolysis and the relative contribution of 
pyruvate to energy production when compared to fasting rats (26). However, previous studies 
have shown that in myocardium recovering from low flow ischemia, hyperglycemia and 
hyperinsulinemia did not increase total carbohydrate or pyruvate oxidation (27). 
The present study focused on pyruvate metabolism. Beyond pyruvate, the development of 
hyperpolarised fatty acids, such as acetate (23) may also allow the study of changes in short 
chain fatty acid metabolism in myocardial ischemia. 
Despite the significant signal gains due to hyperpolarised MR imaging, the limited SNR of the 
detected metabolic products leads to limited spatial resolution. For example, in rats, we could not 
detect small, sub-millimeter areas of infarction However, the spatial resolution achievable is 
comparable to that currently available in clinical SPECT or PET studies, suggesting that it could 
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be rapidly transferred to use in humans. However, improvements in polarisation levels and 
transition to 3D imaging approaches (28) are warranted to further optimize image quality. 
An issue with hyperpolarized imaging is the volume of agent required. It has been found that a 1 
ml injection of a pyruvate concentration of 40 mM maximised H13CO3 production while resulting 
in minimal alteration to in vivo substrate composition (29). We injected a slightly larger volume of 
a similar concentration to allow us overcome the dead volume in the longer lines used while the 
animal was in the scanner. Animals received 1.4 ml of pyruvate followed by 0.3 ml saline flush in 
3-4 separate injections, and a final injection of 0.1 ml gadolinium contrast agent and 0.3 ml saline 
flush at the end of the 4-hour duration of the scan, resulting in a volume of 7.6 ml over the 4-5 
hours of the experiment. In the second experiment, animals received a maximum of 4.2 ml over 
the 3-hour experiment. Each individual injection was approximately the recommended maximum 
bolus of 5 ml/kg, however multiple boluses were given over the duration of the experiment. As a 
result, the total volume given over the duration of the first experiment was above the maximum 
recommended volume for the species of 20ml/kg (30). Unfortunately, giving a smaller volume of 
higher concentration of pyruvate was not possible, as this may inhibit lactate dehydrogenase, 
leading to changes in the lactate/bicarbonate ratio (29). Finally, all animals were monitored for 
distress using a comprehensive scoring system after each stage of the experiments. It should be 
noted that, despite the volumes given, euthanasia was not required in any animal. 
In summary, the present hyperpolarised MR imaging animal study has demonstrated detection of 
local metabolic changes in myocardial ischemia/reperfusion and has identified an acute increase 
in the lactate-to-bicarbonate ratio in the area-at-risk after reperfusion with recovery back to 
baseline by 1 week. Given the translation of the imaging technology to humans (31), the 
approach promises a diagnostic window to assess metabolic changes caused by transient 
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Chapter 8 -   Conclusion 
This thesis focused on the structural and metabolic changes occurring in acute myocardial 
ischemia and reperfusion, using the MRI techniques of T1 mapping and hyperpolarised 
spectroscopic imaging. The work ranged from the development of the animal model, to the 
validation of the imaging tools, to the investigation of the changes in native and post-contrast 
myocardial T1 and pyruvate metabolism following occlusion of the coronary artery and 
reperfusion. 
Initially, the small animal model of coronary occlusion was developed. This enabled us to occlude 
the left coronary artery while the animal remained in the bore of the scanner. This method avoids 
some of the confounders of the open chest myocardial ischemia models. It also allows the 
pattern of myocardial ischemia to be varied, with different durations of myocardial ischemia and 
reperfusion and thereby allowing the study of pre- and postconditioning. This model could also 
be used for other imaging methods, such as nuclear imaging, where the confounders of an open 
thorax were to be avoided, or where access to the animal is limited. 
Our group had already developed and validated a novel technique of myocardial T1 mapping in 
small animals. The SALLI pulse sequence overcomes some of the challenges of high heart rate 
and uses the T1 recovery time to generate inversion-recovery and cine-MR images. This time 
efficient method of imaging was then validated against the gold standard of assessment of left 
ventricular function, conventional cine MR imaging while the LGE inversion recovery images 
were validated against myocardial staining for infarction. 
Using the model developed in Chapter 3, we proceeded to investigate the acute changes in 
myocardial T1 with varying durations of myocardial ischemia. We found that changes in 
myocardial T1 began within the first 15 minutes of ischemia. The myocardial T1 values continued 
to increase slightly with increasing duration of ischemia, but interestingly, did not increase 
significantly following myocardial reperfusion. Myocardial T1 values then remained elevated for 
the next 90 minutes following reperfusion but did not change significantly. 
We then proceeded to investigate the effects of preconditioning on myocardial T1 values. Similar 
to studies using ex-vivo methods of measurement of myocardial oedema, we found that 
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preconditioning led to reduced myocardial oedema. The T1 values rose more slowly and did not 
reach the level of remote myocardium at comparable time points.  
We found that the native T1 values in the AAR changed little from day 0 to day 3 and day 7 and 
remained higher than those of the remote myocardium. It was also true that the post-contrast T1 
values in the area at risk were significantly lower that the remote myocardium at each stage. 
Finally, we studied the acute changes in pyruvate metabolism following a brief period of 
myocardial ischemia. An in-vivo technique of metabolic imaging was first optimised and 
assessed for reproducibility. We found that, following 15 minutes of myocardial ischemia, the 
lactate/bicarbonate ratio was significantly increased in the AAR. This indicated that, although 
myocardial perfusion had resumed, with resumption of systolic function, that the myocardial 
metabolism continued to produce increased levels of lactate from the anaerobic metabolism of 
pyruvate, with reduced aerobic metabolism of pyruvate into the Krebs cycle. This difference 
persisted for the first 60 minutes of myocardial reperfusion. When the metabolism was 
reassessed one week following the ischemic episode, the lactate/bicarbonate ratio in the AAR 
was indistinguishable from the remote myocardium, indicating that the myocardium had returned 
to normal levels of aerobic metabolism. It would be of interest to study the effects of various 
treatments, including conditioning, on myocardial metabolism in ischemia. 
T1 mapping has already progressed from a research tool into wider clinical use. Technical 
challenges, such as long sequence duration or variability at higher heart rates, are being 
addressed with modified shortened sequences. Alternatives to IR methods also exist, including 
saturation recovery methods. These have the advantage the recovery of T1 is measured, rather 
than T1∗  as with IR methods such as MOLLI. Accuracy is improved, as correction for T1∗  is not 
required. It remains to be seen whether the potential gains in accuracy provided by saturation 
recovery methods will result in a practical clinical benefit. 
Spatial resolution plays a significant role in T1 mapping. As the T1 values of blood and 
myocardium are very different, a partial volume effect will have a significant impact on the T1 
value in a voxel at the endocardium for example. It also makes T1 mapping of thinner structures 
such as thin walled infarcts, atria and the right ventricle more demanding. For the purposes of 
small animal imaging, it makes the detection of varying degrees of injury from endocardium to 
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epicardium very challenging. Improvements in parallel imaging may allow increased image 
resolution, but as of yet, T1 mapping does not reach the sensitivity of LGE for the detection of 
small focal injury or fibrosis. 
Although we demonstrated significant changes in myocardial metabolism in a small animal 
model, it may be that a small animal is the most challenging in-vivo model to use for this 
technique. In spite of the enormous increases in SNR obtained with hyperpolarisation, obtaining 
high-resolution imaging remains challenging. Strategies to optimise SNR will in the future include 
improving polarisation, minimising polarisation loss before tracer injection and optimised imaging 
sequences. For example, we had a calculated polarisation of [1-13C]pyruvate of 19% at 30 
seconds following dissolution. Although improvements in pulse sequence and coil technology, 
such as compressed sensing and cryogenic coils, will give improvements in SNR, efforts to 
maximise the polarisation or to minimise polarisation loss before injection of the tracer offer 
larger potential gains. Further improvement in the efficiency and speed of polarisation can be 
expected with the use of new radicals as sources of unpaired electrons, or by first polarising 1H 
before transferring this polarisation to 13C. Outside the bore of the polariser, polarisation can be 
rapidly lost as the T1 of the tracer can become quite short at low fields. An optimal system could 
see the polariser located in the same room, or same device, as the MR scanner, allowing control 
of the magnetic field, and rapid, semi-automatic injection of the tracer. Indeed, as pharmaceutical 
grade tracer is required for injection of human subjects, automatisation of as many aspects of the 
hyperpolarisation process including a quality control system, would lead to improved reproducible 
imaging. 
Hyperpolarised imaging has opened up new areas of physiology to study. Hyperpolarised probes 
such as fumarate are already being used as a non-invasive marker of viability. Further insight 
into cellular biology will be driven by hyperpolarised imaging, and these findings will, in turn, lead 
to improved tracers and metabolic targets for study. As the heart is metabolically an omnivore, 
and can change its source of energy depending on availability, optimised protocols will involve 
the stimulation of various metabolic pathways, and studying the result. For example, our study 
involved the priming of carbohydrate metabolism with the use of a glucose infusion. This then 
allowed the imaging of hyperpolarised [1-13C]pyruvate as the myocardium had switched from 
fatty acids to carbohydrates as its primary source of energy. 
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We have demonstrated that changes in myocardial structure and metabolism are detectable after 
very brief, 15-minute, periods of myocardial ischemia. We found that levels of myocardial 
oedema persisted for at least one week following an ischemic episode. The recovery of 
metabolism followed a different pattern, remaining abnormal but showing a return towards 
baseline in the 60 minutes following ischemia, whereas it had returned to normal one week later. 
This work demonstrated the utility of T1 mapping in assessing the myocardial area at risk. We 
found that T1 values remained elevated in the week following ischemia. This indicates that T1 
mapping could be used to detect acute myocardial injury, and could perhaps be used to 
delineate the myocardial AAR. The AAR could also be detected by the metabolic changes 
following ischemia-reperfusion. In the future, the lactate/bicarbonate ratio could be used to 
estimate the degree of myocardial injury, estimate myocardial viability and measure the AAR. 
Until now, there has been no means of studying the metabolism of the myocardium as it recovers 
from ischemia and no method of studying reperfusion injury in-vivo. The combination of both T1 
mapping and hyperpolarised imaging can provide unique insights into the process of myocardial 
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